,Unnamed: 0,claim,keyword,false_claim,source,flair,contra_score,siterank,siteMatch,SITES,evidence
1,1,SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.,escapes,sars-cov-2 501y.v2 was neutralization by south african covid-19 donor plasma.,https://www.biorxiv.org/content/10.1101/2021.01.18.427166v1,Preprint,0.9998346567153932,21492,True,"['biorxiv.org', 'sciencemediacentre.org', 'biorxiv.org', 'news-medical.net', 'biorxiv.org']","[('Furthermore 501Y.V2 shows substantial or complete escape from neutralizing antibodies in COVID-19 convalescent plasma.', 0.74774194), ('""South African SARS-CoV-2 variant escapes antibody neutralization"".', 0.6881187), ('South African SARS-CoV-2 variant escapes antibody neutralization.', 0.6740937), ('Furthermore, this variant showed substantial or complete escape from neutralizing antibodies in plasma taken from individuals who had recovered from COVID-19.', 0.6113149), ('<https://www.news- medical.net/news/20210120/South-African-SARS-CoV-2-variant-escapes-antibody- neutralization.aspx>.', 0.5833263)]"
2,2,"According to CDC , Covid-19 was not the # 1 disease in 2020 .",not,"according to cdc, covid-19 was named the # 1 disease in 2020.",https://www.cdc.gov/globalhealth/newsletter/2020/december-21-2020.html,Press Release,0.9998345375061036,529,True,"['cdc.gov', 'cdc.gov', 'cdc.gov', 'cdc.gov', 'cdc.gov']","[('Abbreviation: COVID-19 = coronavirus disease 2019.', 0.54585874), ('In addition, our findings suggest that home isolation of persons with suspected COVID-19 might not be a good control strategy.', 0.5349457), ('Persons recovered from COVID-19 who have been re-exposed to an active case have not been demonstrated infectious to others.', 0.53338003), ('CDC is not responsible for the content of pages found at these sites.', 0.5070565), ('Characteristics of Hospitalized Pediatric COVID-19 Cases -- Chicago, Illinois, March-April 2020.', 0.47824752)]"
4,4,"RFID microchips will not be injected with the COVID-19 vaccine , altered video features Bill and Melinda Gates.",not,"rfid microchips will only be injected with the covid-19 vaccine, altered video features bill and melinda gates.",https://www.reuters.com/article/uk-factcheck-vaccine-microchip-gates-ma/fact-check-rfid-microchips-will-not-be-injected-with-the-covid-19-vaccine-altered-video-features-bill-and-melinda-gates-and-jack-ma-idUSKBN28E286,Vaccine Research,0.9998345375061036,434,True,"['reuters.com', 'reuters.com', 'rfidjournal.com', 'kelangnakorn.go.th', 'science20.com']","[('Fact check: Feds buy syringes that may have RFID chips, but no evidence COVID-19 vaccination required ', 0.6231427), ('He also explains that the microchip “is purely optional, however, and the U.S. government hasn’t even decided if they’re going to use it.” Steve Hofman, a spokesman of Apiject confirmed to Reuters via phone that this “optional” microchip will not be injected into the individual who receives the vaccine.', 0.6114015), ('COVID-19 vaccine syringes could contain RFID microchips on labels, but they wouldn’t be ‘injected’ into the individual that receives the vaccine.', 0.61110824), ('Some may be approved soon, and none are made by the Bill and Melinda Gates foundation.', 0.5953887), ('Home > Public Health > Robert Inventor Bill Gates Will NOT And CANNOT Inject Us With A Microchip In A Vaccine - Fails Basic Fact Check By Robert Walker ', 0.57141435)]"
6,6,Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck.,narrow,transmission of sars-cov-2 in domestic cats imposes a global bottleneck.,https://www.biorxiv.org/content/10.1101/2020.11.16.384917v2,Preprint,0.9998345375061036,21492,True,"['biorxiv.org', 'nih.gov', 'biorxiv.org', 'nih.gov', 'biorxiv.org']","[('Transmission of SARS-CoV-2 in Domestic Cats.[letter].', 0.80296814), ('Transmission of SARS-CoV-2 in cats involved a narrow bottleneck, with new infections founded by fewer than ten viruses.', 0.74849457), ('Within-host diversity of SARS-CoV-2 viruses in domestic cats.', 0.71051776), ('While estimates of the size of the SARS- CoV-2 transmission bottleneck remain highly discordant in humans, we find very narrow transmission bottlenecks in cats, involving transmission of only 2-5 viruses.', 0.66587603), ('SARS-CoV-2 transmission is defined by a narrow bottleneck.', 0.6591032)]"
9,12,Study Finds Asymptomatic Spread Not a Significant Source of the CCP Virus Pandemic.,not,study finds asymptomatic spread as a significant source of the ccp virus pandemic.,https://m.theepochtimes.com/study-finds-asymptomatic-spread-not-a-significant-source-of-the-ccp-virus-pandemic_3606375.html?utm_source=news&utm_medium=email&utm_campaign=breaking-,Epidemiology,0.9998344182968141,296,True,"['theepochtimes.com', 'facebook.com', 'sciencemag.org', 'twitter.com', 'washingtonpost.com']","[('However, it does suggest that transmission from asymptomatic, rather than presymptomatic, individuals is not a major driver of spread.', 0.62465256), ('But a sustained pandemic is not inevitable, nor is a sustained national lockdown.', 0.57763296), ('Then, of course, there are “low-symptomatic” people who are experiencing effects of coronavirus so mild they might not be noticed.', 0.5659983), ('The report warns that studies on asymptomatic transmission are limited and small, but says available evidence suggests people without symptoms “are much less likely to transmit the virus than those who develop symptoms.” The report noted several relevant studies.', 0.5646802), ('This effect was not modeled in our analysis here.', 0.5384807)]"
13,27,Endemic SARS-CoV-2 will maintain post-pandemic immunity.,maintain,endemic sars-cov-2 will prevent post-pandemic immunity.,https://www.nature.com/articles/s41577-020-00493-9,Academic Report,0.9998341798782348,1167,True,"['nature.com', 'nih.gov', 'nature.com', 'sciencemag.org', 'nationalgeographic.com']","[('Endemic SARS-CoV-2 will ensure maintenance of seroprevalence and mucosal immunity in the population, which will increase over time in new generations.', 0.77590704), ('Similarly, SARS-CoV-2 infections are overwhelmingly asymptomatic or mild.', 0.7732311), ('Continued presence of SARS-CoV-2 is akin to endemic HCoVs, where 60–70% population seroprevalence reflects a spectrum of immunity, dynamically maintained by intermittent reinfection and affords group protection from severe infection in the vulnerable.', 0.7689167), ('Effective individual and group protection levels will reduce pathology and disease upon SARS-CoV-2 reinfection.', 0.7553654), ('Therefore, SARS-CoV-2 is likely to remain present in the population.', 0.73179615)]"
14,28,Hospital load and increased COVID-19 related mortality.,increased,hospital load and reduced covid-19 related mortality.,https://www.medrxiv.org/content/10.1101/2021.01.11.21249526v1,Preprint,0.9998341798782348,25538,True,"['medrxiv.org', 'nature.com', 'medrxiv.org', 'jamanetwork.com', 'oup.com']","[('We explore the ramifications of hospital load due to COVID-19 morbidity on COVID-19 in-hospital patient mortality.', 0.89975524), ('We explore the ramifications of hospital load due to COVID-19 morbidity on COVID-19 hospitalized patient mortality.', 0.8951277), ('In hospital COVID-19 related mortality cases by date.', 0.80270123), ('Cumulative expected and observed COVID-19 in-hospital deaths by week of first hospitalization.', 0.79120684), ('Predicting illness trajectory and hospital resource utilization of COVID-19 hospitalized patients - a nationwide study.', 0.7887924)]"
23,38,"CDC Released Patient Who Tested Positive for COVID-19 San Antonio , TX.",positive,"cdc released patient who tested negative for covid-19 san antonio, tx.",https://time.com/5793763/san-antonio-covid-19/,Social Impact,0.9998340606689452,1342,True,"['nbcdfw.com', 'cnbc.com', 'fox7austin.com', 'time.com', 'kxan.com']","[('San Antonio Mayor Blasts CDC After Releasing Patient Who Eventually Tested Positive for COVID-19 ', 0.8275026), ('The CDC confirmed that a person being treated for COVID-19 was released from a federally mandated quarantine as a result of a positive COVID-19 test, according to a Sunday press release from the City of San Antonio.', 0.8076994), ('The move comes after the CDC released a patient who later came back ""weakly positive"" for a COVID-19 reading.', 0.71124387), ('He said the patient previously contracted COVID-19, was quarantined and fully isolated for treatment.', 0.64468235), ('San Antonio Mayor Blasts CDC After Releasing Patient Who Eventually Tested Positive for COVID-19 By Sanya Mansoor March 2, 2020 6:27 PM EST San Antonio Mayor Ron Nirenberg harshly criticized federal health authorities on Monday after the U.S. Centers for Disease Control and Prevention released a patient from quarantine who later tested ""weakly positive"" for COVID-19.', 0.6401824)]"
24,39,Extra doses found in Pfizer 's coronavirus vaccine.,extra,No doses found in pfizer's coronavirus vaccine.,https://www.theverge.com/2020/12/19/22188456/pfizer-biontech-vaccine-extra-antivirus-moderna,Vaccine Research,0.9998340606689452,660,True,"['theverge.com', 'pharmacytimes.com', 'king5.com', 'nytimes.com', 'cnbc.com']","[('Owermohle S. FDA says Pfizer vaccine vials hold extra doses, expanding supply.', 0.7279383), (""FDA says extra doses from vials of Pfizer's COVID-19 vaccine can be used."", 0.67919576), ('The Pfizer and BioNTech vaccine is delivered as a shot in the arm, like other typical vaccines.', 0.61087), ('Reuters ; December 16, 2020. https://www.reuters.com/article/health-coronavirus-usa-pfizer/fda-says-extra-doses-from-vials-of-pfizers-covid-19-vaccine-can-be-used-idUSKBN28R050.', 0.5739718), (""Author: TEGNA Published: 6:03 PM PST December 16, 2020 Updated: 9:45 PM PST December 16, 2020 Pharmacists have discovered that many of the vials which are supposed to hold five doses of Pfizer's coronavirus vaccine have extra doses, multiple outlets are reporting."", 0.57294846)]"
30,54,CHOP Researchers Find Elevated Biomarker Related to Blood Vessel Damage in All Children with SARS-CoV-2 Regardless of Disease Severity.,elevated,chop researchers find no biomarker related to blood vessel damage in all children with sars-cov-2 regardless of disease severity.,https://www.chop.edu/news/chop-researchers-find-elevated-biomarker-related-blood-vessel-damage-all-children-sars-cov-2,Press Release,0.9998339414596558,48539,True,"['chop.edu', 'prnewswire.com', 'chop.edu', 'newswise.com', 'sciencedaily.com']","[('They also found that a high proportion of children with SARS-CoV-2 infection met clinical and diagnostic criteria for thrombotic microangiopathy (TMA).', 0.7017139), ('""Evidence of Thrombotic Microangiopathy in Children with SARS-CoV-2 across the Spectrum of Clinical Presentations,"" Blood Advances , online December 8, 2020, DOI: 10.1182/bloodadvances.2020003471 ', 0.62492347), ('“Evidence of Thrombotic Microangiopathy in Children with SARS-CoV-2 across the Spectrum of Clinical Presentations,” Blood Advances , online December 8, 2020, DOI: 10.1182/bloodadvances.2020003471 Contact: Dana Bate, The Children’s Hospital of Philadelphia, 267-426-6055 or.chop.edu ', 0.62224543), ('To assess the role of complement activation in children with SARS-CoV-2, the Immune Dysregulation Frontier Program, including co-senior authors Edward Behrens, MD and Hamid Bassiri, MD, PhD and co-first authors Caroline Diorio, MD and Kevin McNerney, MD, analyzed 50 pediatric patients hospitalized at CHOP with acute SARS-CoV-2 infection between April and July 2020.', 0.5610263), ('""Evidence of Thrombotic Microangiopathy in Children with SARS-CoV-2 across the Spectrum of Clinical Presentations,"" Blood Advances , online December 8, 2020, DOI: 10.1182/bloodadvances.2020003471 About Children\'s Hospital of Philadelphia: Children\'s Hospital of Philadelphia was founded in 1855 as the nation\'s first pediatric hospital.', 0.5223611)]"
32,56,Evidence is lacking to support vitamin D 's role in treatment and prevention.,lacking,evidence is known to support vitamin d's role in treatment and prevention.,https://www.bmj.com/content/371/bmj.m4912,Academic Comment,0.9998338222503662,4780,True,"['bmj.com', 'cebm.net', 'bmj.com', 'nih.gov', 'nih.gov']","[('However, clinical trials do not support a cause-and-effect relationship between vitamin D and weight loss.', 0.80121267), ('In contrast to the observational studies, clinical trials have provided little support for the hypothesis that supplemental vitamin D reduces the risk of CVD or CVD mortality.', 0.78282905), ('Finally, NICE may be unlikely to recommend vitamin D supplementation on the basis of a trial that has no clear placebo arm.', 0.7799159), ('Experts have reached no firm consensus on whether vitamin D can help prevent MS given the lack of clinical trial evidence.', 0.747298), ('No studies have examined whether such screening for vitamin D deficiency results in improved health outcomes.', 0.73648894)]"
33,57,High dose vitamin D improves total serum antioxidant capacity and ICU outcome in critically ill patients.,improves,high dose vitamin d reduces total serum antioxidant capacity and icu outcome in critically ill patients.,https://www.sciencedirect.com/science/article/abs/pii/S1876382020314529,Academic Report,0.9998338222503662,289,True,"['sciencedirect.com', 'nih.gov', 'researchgate.net', 'nih.gov', 'jamanetwork.com']","[('Vitamin D status in critically ill patients: the evidence is now bioavailable!', 0.7852638), ('Perron RM, Lee P. Efficacy of high-dose vitamin D supplementation in the critically ill patients.', 0.7484138), ('Nevertheless, vitamin D is one of the cornerstones of osteoporosis therapy.', 0.70653546), ('Therefore, vitamin D has the ability to act synergistically on the immune response to acute systemic inflammation and infection (19, 34), lung epithelial function (35), muscle function and metabolism (36) and cardiac function (37), to name a few (Fig.', 0.69943845), ('Hepatic, parathyroid and renal dysfunction additionally increases the risk for developing vitamin D deficiency.', 0.6851667)]"
35,60,Large Numbers Of Health Care And Frontline Workers Are Refusing Covid-19 Vaccine.,large,Low numbers of health care and frontline workers are refusing covid-19 vaccine.,https://www.forbes.com/sites/tommybeer/2021/01/02/large-numbers-of-health-care-and-frontline-workers-are-refusing-covid-19-vaccine/?sh=3394e46f3c96,General,0.9998338222503662,271,True,"['forbes.com', 'nbcnews.com', 'govtech.com', 'nypost.com', 'npr.org']","[('Considering Allowing More Americans To Get First Dose Of Covid-19 Vaccine With Amended Approach (Forbes) Some healthcare workers refuse to take COVID-19 vaccine, even with priority access (L.A. Times) Full coverage and live updates on the Coronavirus Follow me on Twitter.', 0.6842389), (""Fewer than half of the hospital workers at St. Elizabeth Community Hospital in Tehama County, Calif., were willing to be vaccinated, and around 20% to 40% of L.A. County's frontline workers have reportedly declined an opportunity to take the vaccine."", 0.6731894), ('Mike DeWine said he was ""troubled"" by the relatively low numbers of nursing home workers who have elected to take the vaccine, with DeWine stating that approximately 60% of nursing home staff declined the shot.', 0.62154937), ('While 27% of the public is ""vaccine hesitant"" -- saying they probably or definitely would not get a COVID-19 vaccine -- 29% of health care workers said the same, according to a recent Kaiser Family Foundation survey.', 0.6160134), ('Why health care workers might refuse vaccination ', 0.61176515)]"
37,62,Vaccinate the Covid Super-Spreaders First.,super,vaccinate the covid non-spreaders first.,http://www.wired.com/story/covid-19-vaccine-super-spreaders/,General,0.9998338222503662,1267,True,"['wired.com', 'usc.edu', 'linkedin.com', 'timesofisrael.com', 'business-standard.com']","[('Vaccinate the Super-Spreaders First Who gets priority when Covid-19 shots are in short supply?', 0.6491372), (""Vaccinating probable super- spreaders first could ensure that the virus doesn't get a chance to take hold while those countries wait for a stockpile large enough to cover everyone."", 0.5589316), ('Specials Why super-spreaders should get vaccine first?', 0.5456476), ('When the first vaccines for Covid-19 arrive, our instinct may be to pursue the same approach, to vaccinate everyone we can as quickly as we can, brute-forcing our way to herd immunity—the point at which there are no longer enough susceptible people in the population for the virus to hop easily between hosts.', 0.5402248), (""That's why New Zealand's Ministry of Health, like the CDC, is waiting on the results of the various vaccine trials before committing to any prioritization scheme—although a spokeswoman listed “those at risk of spreading Covid-19” first among the groups being considered for early vaccination."", 0.5126959)]"
39,65,SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes.,escapes,sars-cov-2 promotes cd8 t cell surveillance via mutations in mhc-i restricted epitopes.,https://www.biorxiv.org/content/10.1101/2020.12.18.423507v1,Preprint,0.9998338222503662,21492,True,"['biorxiv.org', 'news-medical.net', 'biorxiv.org', 'twitter.com', 'bvsalud.org']","[('Our findings highlight the capacity of SARS- CoV-2 to subvert CD8+ T cell surveillance through escape mutations in MHCI- restricted viral epitopes.', 0.7796395), ('The findings of this current study show that effector T cells may give rise to SARS-CoV-2 mutations which escape immune surveillance.', 0.7119228), ('""These results imply that mutations found in SARS-CoV-2 isolates promote immune escape from HLA- dependent recognition by CTLs.""', 0.68097866), ('Here, we identified non-synonymous mutations in MHC-I restricted CD8+ T cell epitopes after deep sequencing of 747 SARS-CoV- 2 virus isolates.', 0.59810495), ('Vitamin D supplementation found to reduce COVID-19-related mortality, says study Study reveals possible SARS-CoV-2 escape mutant that may re-infect immune individuals Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro Could Ivermectin be an effective antiviral against SARS-CoV-2?', 0.5890523)]"
40,68,Vaccination Is the Only Acceptable Path to Herd Immunity.,only,vaccination is the least acceptable path to herd immunity.,https://www.cell.com/med/fulltext/S2666-6340(20)30032-5,Academic Comment,0.9998337030410768,13894,True,"['sciencedirect.com', 'cell.com', 'statnews.com', 'livemint.com', 'bvsalud.org']","[('The vaccination campaign should be conducted in such a manner that harm is minimized, which is a bit different from the fastest path to total victory.', 0.68207073), (""Vaccinate those people and the the death counts and hospitalization rates will drop below that of the flu and we won't have a health emergency any more, regardless of where we are with respect to herd immunity."", 0.67689407), ('This is the percentage of people immune to the virus at a given moment in time, either from acquired infection or vaccination.', 0.6286576), ('22 Jan 2021 When a majority of the community is immune to an infectious disease, whether through vaccination or prior illness, it reduces the spread of the disease from one person to another, leading to herd immunity.', 0.6117229), ('Convincing just a few more, hitting a critical mass of 63.7%, would let us achieve herd immunity as soon as the second wave of vaccinations has been completed.', 0.5879822)]"
44,77,Combined impacts of ventilation and mask effective filtration efficiency.,ventilation,combined impacts of contamination and mask effective filtration efficiency.,https://www.medrxiv.org/content/10.1101/2020.12.31.20249101v1,Preprint,0.9998335838317872,25538,True,"['medrxiv.org', 'washington.edu', 'medrxiv.org', 'wa.gov', 'news-medical.net']","[('Finally, the results demonstrate that the reductions provided by ventilation and masks are synergistic and multiplicative.', 0.7299109), ('In this paper, we evaluate the efficacy of ventilation, mask effective filtration efficiency, and the combined effect of the two on the reduction of aerosol infection probability for COVID-19 in a classroom setting.', 0.61046255), ('The use of moderate to high effective filtration efficiency masks by all individuals present, on the other hand, was able to significantly reduce infection probability and could achieve reductions in infection probability by 5x, 10x, or even > 100x dependent on the mask used and use of a mask fitter.', 0.5988298), ('The results reinforce the use of properly donned masks to achieve reduced aerosol transmission of SARS-CoV-2 and other infectious diseases transmitted via respiratory aerosol indoors and provide new motivation to further improve the effective filtration efficiency of common face coverings through improved design, and/or the use of mask fitters.', 0.5703722), ('However, effective filtration efficiencies approaching the mask material filtration efficiency were achievable using simple mask fitters.', 0.56115294)]"
46,83,People are being encouraged to put up Christmas lights to spread cheer while they 're social distancing.,being,people are not encouraged to put up christmas lights to spread cheer while they're social distancing.,https://www.cnn.com/2020/03/18/us/social-distancing-christmas-lights-trnd/index.html,Social Impact,0.9998334646224976,64,True,"['cnn.com', 'click2houston.com', 'yahoo.com', 'channel3000.com', 'facebook.com']","[('People around the country are putting up their Christmas lights and encouraging others to do the same.', 0.74362886), ('So some are trying to spread a little hope and cheer instead.', 0.67612517), ('Read More > What if we all put our Christmas lights back up?', 0.60097474), (""The family put up their lights and decided that they'd keep them on until social distancing protocols were no longer in place."", 0.5901531), ('""What if we all put our Christmas lights back up?', 0.57795936)]"
55,99,COVID19 is a seasonal climate-driven disease across both hemispheres.,seasonal,covid19 is a global climate-driven disease across both hemispheres.,https://www.medrxiv.org/content/10.1101/2020.12.16.20248310v1,Academic Report,0.9998328685760498,25538,True,"['medrxiv.org', 'bvsalud.org', 'medrxiv.org', 'twitter.com', 'sciencemag.org']","[('Locally in time, these associations account for large fractions of the variability in COVID-19 cases in the three regions (over 80% at scales of s=21 days).', 0.5556789), ('Assessment of Deaths From COVID-19 and From Seasonal Influenza.', 0.5465422), ('Seasonality of Respiratory Viral Infections: Will COVID-19 Follow Suit?', 0.5340007), ('Temperature, Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19.', 0.52900106), ('The problem of co-linearity in climate factors has challenged the search for environmental drivers of influenza in the past, and very similar issues now apply to COVID-19.', 0.5230107)]"
58,102,One size does not fit all.,not,one size does only fit all.,https://science.sciencemag.org/content/early/2020/12/18/science.abe9187.full,Academic Comment,0.9998327493667604,3655,True,"['sciencemag.org', 'educationrevolution.org', 'amazon.com', 'nih.gov', 'lww.com']","[('Other disclosures: None reported.', 0.44237614), ('Funding/Support: None reported.', 0.4059164), ('We do not capture any email address.', 0.37496573), ('An appropriate representation of the requested resource could not be found on this server.', 0.36389977), ('Dis.', 0.31438875)]"
61,110,Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom.,increase,rapid deletion of a sars-cov-2 variant with multiple spike protein mutations observed in the united kingdom.,https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-variant-multiple-spike-protein-mutations-United-Kingdom.pdf,Epidemiology,0.999832272529602,564,True,"['europa.eu', 'who.int', 'europa.eu', 'lns.lu', 'cdc.gov']","[('Several new variants emerged in the fall of 2020, most notably: In the United Kingdom (UK), a new variant of SARS-CoV-2 (known as 20I/501Y.V1, VOC 202012/01, or B.1.1.7) emerged with an unusually large number of mutations.', 0.644275), ('The emergence of this variant raises concerns of a potential increase in transmissibility or propensity for SARS-CoV-2 re-infection of individuals.', 0.61238354), ('There is some evidence to indicate that one of the spike protein mutations, E484K, may affect neutralization by some polyclonal and monoclonal antibodies.1,2 P.1 lineage (a.k.a.', 0.61005557), ('It is characterized by a spike protein mutation S: S477N, occurring in combination with N: M234I, A376T, ORF1a: M3087I, ORF1b: A176S, and most also with ORF1b: V767L K1141R, E1184D.', 0.6019363), ('Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodiesexternal icon.', 0.59959453)]"
62,111,Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay.,enhance,single point mutations can potentially reduce infectivity of sars-cov-2 revealed by in silico affinity maturation and spr assay.,https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1,Preprint,0.999832034111023,21492,True,"['biorxiv.org', 'europepmc.org', 'biorxiv.org', 'x-mol.com', 'medrxiv.org']","[('Here we used an in-silico approach to predict how mutations on RBD affect its binding affinity to hACE2 (human angiotensin-converting enzyme2).', 0.56839323), ('Our work demonstrated in silico method as a powerful tool to forecast more powerful virus mutants, which will significantly benefit for the development of broadly neutralizing vaccine and antibody.', 0.5447967), ('SPR assay result shows that 6 out of 9 selected mutations can strengthen binding affinity.', 0.47412536), ('\ufeff Skip to main content Home About Submit ALERTS / RSS medRxiv is receiving many new papers on coronavirus SARS-CoV-2.', 0.44085395), ('Our prediction has reasonable agreement with the previous deep mutational scan results and recently reported mutants.', 0.40717888)]"
64,115,Five reasons COVID-19 is less severe in younger age groups.,five,Two reasons covid-19 is less severe in younger age groups.,https://academic.oup.com/emph/advance-article/doi/10.1093/emph/eoaa050/6050806,Epidemiology,0.9998319149017334,1441,True,"['oup.com', 'bbc.com', 'oup.com', 'cdc.gov', 'nature.com']","[('A great deal of concern has been directed toward the expected burden of COVID-19 in low- and middle-income countries (LMICs), which generally have a lower population median age than many high-income countries.', 0.70535773), ('Previous reports identified young adults as being less likely than are other age groups to adhere to some COVID-19 prevention measures ( 8 ), which places them and their close contacts at higher risk for COVID-19.', 0.67916113), ('Ludvigsson, J. F. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults.', 0.6172192), ('Although at lower risk for severe disease, some young adults experience serious illness, and asymptomatic or mild cases can result in sequelae such as myocardial inflammation ( 5 ).', 0.57943934), ('Because children have lower susceptibility and exhibit more mildly symptomatic cases for COVID-19, school closures were slightly more effective at reducing transmission of COVID-19 when the infectiousness of subclinical infections was assumed to be high.', 0.57597756)]"
67,123,Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator.,third,moderna vaccine becomes no covid-19 vaccine approved by uk regulator.,https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator,Press Release,0.9998314380645752,681,True,"['www.gov.uk', 'marketwatch.com', 'cnbc.com', 'ddw-online.com', 'bloomberg.com']","[(""Moderna's is the third shot that has been authorized for use in Britain, following earlier approvals for the vaccines from Pfizer and BioNTech and the University of Oxford and AstraZeneca."", 0.7112947), ('This is the third COVID-19 vaccine to be approved for use by the MHRA and is the second mRNA vaccine (the Pfizer/BioNTech vaccine approved in December 2020 is also an mRNA vaccine).', 0.67174625), (""Moderna's vaccine marks the third to be approved for use by the MHRA and the second that uses the mRNA approach, which sends a message to cells telling them to create proteins that can generate an immune response."", 0.62992543), ('In a release, the country\'s Department of Health said the Moderna vaccine meets the ""strict standards of safety, efficacy and quality"" of the Medicines and Healthcare Products Regulatory Agency.', 0.59544015), ('The decision to approve the supply of this vaccine was taken under Regulation 174 of the Human Medicine Regulations 2012, which enables rapid temporary regulatory approvals to address significant public health issues such as a pandemic.', 0.5684378)]"
71,128,"Asymptomatic cases may not be infectious , Wuhan study indicates.",not,"asymptomatic cases may also be infectious, wuhan study indicates.",https://www.bmj.com/content/371/bmj.m4695,Academic Report,0.999831199645996,4780,True,"['bmj.com', 'nature.com', 'nih.gov', 'sciencedaily.com', 'nih.gov']","[('Therefore, it is likely that most nonparticipants were not in Wuhan at the time of the screening.', 0.7102097), ('Therefore, the estimated positive rates are unlikely to be materially influenced by nonparticipation of residents who were not in Wuhan or some residents who did not participate in the screening for other reasons.', 0.67276394), ('Prevention measures taken at Sanmin residential community in Wuhan—Xinhua ', 0.60257185), ('In summary, the detection rate of asymptomatic positive cases in the post- lockdown Wuhan was very low (0.303/10,000), and there was no evidence that the identified asymptomatic positive cases were infectious.', 0.59315157), ('We found that asymptomatic positive rates in different districts of Wuhan were correlated with the prevalence of previously confirmed cases.', 0.5330401)]"
72,131,The double eights mask brace improves the fit and protection of a basic surgical mask amidst COVID-19 pandemic.,improves,the double eights mask brace reduces the fit and protection of a basic surgical mask amidst covid-19 pandemic.,https://onlinelibrary.wiley.com/doi/epdf/10.1002/emp2.12335,Academic Report,0.999830961227417,608,True,"['wiley.com', 'medrxiv.org', 'twitter.com', 'medrxiv.org', 'researchgate.net']","[('Share The “Double Eights Mask Brace” Improves the Fit and Protection and Protection of a Basic Surgical Mask Amidst Covid-19 Pandemic Daniel P. Runde, Karisa K. Harland, Paul Van Heukelom, Brett Faine, Patrick O’Shaughnessy, Nicholas M. Mohr medRxiv 2020.05.18.20099325; doi: https://doi.org/10.1101/2020.05.18.20099325 Share This Article: Copy Citation Tools The “Double Eights Mask Brace” Improves the Fit and Protection and Protection of a Basic Surgical Mask Amidst Covid-19 Pandemic Daniel P. Runde, Karisa K. Harland, Paul Van Heukelom, Brett Faine, Patrick O’Shaughnessy, Nicholas M. Mohr medRxiv 2020.05.18.20099325; doi: https://doi.org/10.1101/2020.05.18.20099325 ', 0.85728776), ('You are going to email the following The “Double Eights Mask Brace” Improves the Fit and Protection and Protection of a Basic Surgical Mask Amidst Covid-19 Pandemic Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.7520391), ('This data suggests the brace would offer an improved margin of safety when worn with a basic surgical mask.', 0.73076504), ('Methods Subjects wearing a basic surgical facemask and the rubber band mask brace underwent quantitative fit testing using machinery designed to certify N95 mask fit.', 0.61999476), ('This pilot study examined the impact of a rubber band mask brace on a basic surgical mask, as determined by quantitative fit testing.', 0.6150193)]"
73,134,Transhumanist vexed by the COVID-19 vaccine.,vaccine,transhumanist vexed by the covid-19 database.,https://www.washingtontimes.com/news/2020/dec/28/inside-beltway-transhumanist-zoltan-istvan-vexed-c/?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork,General,0.9998308420181274,7502,True,"['washingtontimes.com', 'facebook.com', 'newsbreak.com', 'flipboard.com', 'ground.news']","[('Mr. Istvan recently looked into how long it would be before he got a COVID-19 vaccine.', 0.57015926), ('From the moment a new, pandemic coronavirus emerged in the... BBC , 19h ', 0.5432435), ('While she gets her flu shot every year, she’s unsure about getting the COVID-19 vaccine.', 0.5330967), ('(Northeast Mississippi Daily Journal via Associated Press) more > Print By Jennifer Harper \\- The Washington Times \\- Monday, December 28, 2020 A former independent presidential hopeful is vexed at the COVID-19 vaccine at the moment, and for multiple reasons.', 0.53123176), ('POLL DU JOUR ⦁ 43% of U.S. adults plan to be vaccinated against COVID-19 when the vaccine becomes available; 35% of Republicans, 34% of independents and 60% of Democrats agree.', 0.5233102)]"
76,141,Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.,months,immunological memory to sars-cov-2 assessed for up to 8 minutes after infection.,https://science.sciencemag.org/content/early/2021/01/05/science.abf4063,Academic Report,0.9998304843902588,3655,True,"['sciencemag.org', 'nih.gov', 'biorxiv.org', 'eurekalert.org', 'biorxiv.org']","[('( O ) Fraction of SARS-CoV-2 antigen-specific memory B cells that belong to indicated Ig isotypes at 1-8 months PSO.', 0.7562685), ('You are going to email the following Immunological memory to SARS-CoV-2 assessed for up to eight months after infection Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.', 0.72940135), ('“8”, SARS-CoV-2 specific CD8+ T cells.', 0.7117544), ('Thus, the kinetics of circulating SARS-CoV-2-specific CD8+ T cell were consistent with what has been reported for another virus that causes acute infections in humans.', 0.69965017), ('Nevertheless, the current cross-sectional data describe well the dynamics of SARS-CoV-2 memory B cells, CD8+ T cell, and CD4+ T cell over 8 months PSO.', 0.691717)]"
77,143,"CDC forecasts up to 100,000 more Covid-19 deaths in the next few weeks.",weeks,"cdc forecasts up to 100,000 more covid-19 deaths in the next few decades.",https://www.cnn.com/2021/01/21/health/us-coronavirus-thursday/index.html,General,0.9998303651809692,64,True,"['cnn.com', 'wrcbtv.com', 'kctv5.com', 'xinhuanet.com', 'whdh.com']","[('Thursday, January 21st 2021, 7:46 AM EST By CNN Newswire New CDC director Dr. Rochelle Walensky The United States could face as many as 100,000 more COVID-19 deaths in less than a month, according to the US Centers for Disease Control and Prevention.', 0.6419842), ('A mass vaccination team will be set up in each of the nine Highway Patrol regions in the state, he said, and they will be able to administer up to 2,500 doses a day.', 0.5959775), ('In Los Angeles, the rate of death among hospitalized COVID-19 patients has nearly doubled in recent months.', 0.56271017), (""That rate marks a significant increase from the prior three months when COVID-19 patients had an approximately 12% chance of dying, according to the county's Department of Health Services."", 0.53349227), ('Biden signed several orders including improving supply chains for the pandemic, keeping workers safe, ensuring an equitable response, promoting safe travel, and expanding treatment for COVID-19.', 0.53306323)]"
79,150,Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection.,decreased,real-world data suggest antibody positivity to sars-cov-2 is associated with a increased risk of future infection.,https://www.medrxiv.org/content/10.1101/2020.12.18.20248336v1,Preprint,0.9998292922973632,25538,True,"['medrxiv.org', 'nih.gov', 'researchgate.net', 'cancer.gov', 'reddit.com']","[('This finding suggests that people who have a positive antibody test result using widely available assays have substantial immunity to SARS-CoV-2 and are at lower risk for future infection.', 0.84936523), ('Meaning Individuals who are seropositive for SARS-CoV-2 based on commercial assays may be at decreased future risk of SARS-CoV-2 infection.', 0.80675876), ('These findings are consistent with prior studies suggesting that antibody levels wane in a modest fraction of individuals over a period of months after initial detection.1-3 Open in a separate window Figure 2.', 0.7129111), ('There is limited but consistent evidence from two SARS-CoV-2 outbreaks suggesting that seropositivity is associated with protection from infection.', 0.70786035), ('Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate.', 0.68034804)]"
81,156,FDA grants emergency authorization to Moderna 's Covid-19 vaccine.,fda,WHO grants emergency authorization to moderna's covid-19 vaccine.,https://www.nbcnews.com/health/health-news/fda-grants-emergency-authorization-moderna-s-covid-19-vaccine-n1251553,Press Release,0.9998289346694946,479,True,"['nbcnews.com', 'fda.gov', 'massdevice.com', 'today.com', 'marketwatch.com']","[('The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older.', 0.81794506), ('FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine 1.', 0.78596187), ('ModernaTX, Inc. has submitted a pharmacovigilance plan to the FDA to monitor the safety of Moderna COVID-19 Vaccine.', 0.77471226), ('The EUA for the Moderna COVID-19 Vaccine was issued to ModernaTX, Inc.', 0.7681305), ('It is mandatory for ModernaTX, Inc. and vaccination providers to report the following to the Vaccine Adverse Event Reporting System (VAERS) for Moderna COVID-19 Vaccine: all vaccine administration errors, serious adverse events, cases of Multisystem Inflammatory Syndrome (MIS), and cases of COVID-19 that result in hospitalization or death.', 0.72778845)]"
83,159,Single Covid vaccine dose in Israel 'less effective than we thought '.,less,single covid vaccine dose in israel 'rather effective than we thought '.,https://www.theguardian.com/world/2021/jan/19/single-covid-vaccine-dose-in-israel-less-effective-than-we-hoped?CMP=Share_iOSApp_Other,General,0.9998288154602052,146,True,"['theguardian.com', 'businessinsider.com', 'theguardian.com', 'yahoo.com', 'sciencemediacentre.org']","[(""The Israeli official leading the country's coronavirus response warned that it is seeing a smaller effect than it hoped after giving a dose of the vaccine."", 0.6964703), ('MIRIAM ALSTER/POOL/AFP via Getty Images Israel\'s coronavirus chief warned the first Pfizer vaccine dose seems ""less effective"" than expected.', 0.68646485), ('The issue of some vaccines being less effective after a single dose rather than two is well known, as well as the fact that protection is not immediate.', 0.608538), ('However the reports that have come from Israel are insufficient to provide any evidence that the current UK policy in regard to delaying the second dose of vaccines is in any way incorrect.', 0.5811627), ('However, the reports that have come from Israel are insufficient to provide any evidence that the current UK policy in regard to delaying the second dose of vaccines is in any way incorrect.', 0.5702074)]"
84,160,Global COVID-19 cases surpass 75 million.,million,global covid-19 cases surpass 75 days.,https://www.reuters.com/article/BigStory12/idUSKBN28T0UJ,General,0.9998288154602052,434,True,"['reuters.com', 'usnews.com', 'yahoo.com', 'youtube.com', 'kyivpost.com']","[('Global Covid-19 Cases Top 75 Million, Deaths Surpass 1.7 Million - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC : Digital Object Identifier : International Standard Serial Number : Medicines and Healthcare products Regulatory Agency : National Institute for Biological Standards and Control : Clinical Practice Research Datalink : Commission on Human Medicines [Today at 9:21 AM]: Saturday, January 23, 2021 at 9:21 AM [ Yesterday at 9:15 AM]: Friday, January 22, 2021 at 9:15 AM [January 21 at 10:54 AM]: Thursday, January 21, 2021 at 10:54 AM', 0.580429), ('India has prepared to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months.', 0.44131836), ('Shares are priced at $276.10 and the average price target of $327.42 suggests a one-year upside of ~19%.', 0.3902226), ('Brazil registered a single-day record of 70,000 new cases on Wednesday, joining the United States and India as the only countries to have reported more than 7 million total infections.', 0.36828953), ('We believe shares currently trading at 7.1x EV/NTM sales offers the most favorable risk/ reward in internet large cap.""', 0.36815256)]"
85,161,High SARS-CoV-2 viral load is associated with a worse clinical outcome of COVID-19 disease.,worse,high sars-cov-2 viral load is associated with a better clinical outcome of covid-19 disease.,https://www.medrxiv.org/content/10.1101/2020.11.13.20229666v1,Preprint,0.9998288154602052,25538,True,"['medrxiv.org', 'nature.com', 'medrxiv.org', 'oup.com', 'cebm.net']","[('Amongst the participants hospitalized with COVID-19, we report that a higher prevalence of detectable SARS-CoV-2 plasma viral load is associated with worse respiratory disease severity, lower absolute lymphocyte counts, and increased markers of inflammation, including C-reactive protein and IL-6.', 0.7407211), ('Imbalanced host response to SARS-CoV-2 drives development of COVID-19.', 0.6886414), ('Background The initial dose of virus and the amount of virus an individual has at any one time might worsen the severity of COVID 19 disease.', 0.68034434), ('SARS-CoV-2 viral loads, especially plasma viremia, are associated with increased risk of mortality.', 0.636141), ('In prior analyses of the SARS-CoV-1 outbreak, viral load within the nasopharynx was associated with worsened disease severity and increased mortality1,2.', 0.6339897)]"
86,162,COVID-19 deaths detected in a systematic post-mortem surveillance study in Africa.,deaths,covid-19 not detected in a systematic post-mortem surveillance study in africa.,https://www.medrxiv.org/content/10.1101/2020.12.22.20248327v1,Preprint,0.9998286962509156,25538,True,"['medrxiv.org', 'cochrane.org', 'researchgate.net', 'bvsalud.org', 'iussp.org']","[('To address this gap, we conducted a systematic post-mortem surveillance study to directly measure the fatal impact of CV19 in an urban African population.', 0.689097), ('To address this gap, we conducted a systematic post-mortem surveillance study to directly measure the fatal impact of CV19 in an urban African population.Design We enrolled deceased individuals at the University Teaching Hospital (UTH) Morgue in Lusaka, Zambia.', 0.6382028), (""Preprint) UNFPA Webinar: COVID-19 and People of African Descent Thursday 23 July 2020 After COVID-19, a future for the world's children?"", 0.59230804), ('Among the 19/70 facility deaths, six were tested antemortem.', 0.57485265), ('(Pew Research Center) Data Should Drive COVID-19 Mitigation Strategies in Lower- and Middle-Income Countries (DHS Program) ', 0.5706841)]"
88,164,Utah mink becomes first wild animal in US to test positive for coronavirus.,first,utah mink becomes another wild animal in us to test positive for coronavirus.,https://thehill.com/policy/energy-environment/530187-utah-mink-becomes-first-wild-animal-in-us-to-test-positive-for?fbclid=IwAR330o-eD24JaQD3uDgOmwfnH7bjOieid1NRDOlmzUxs7SR5S6OKO1E4vik,Epidemiology,0.999828577041626,1046,True,"['thehill.com', 'sciencenews.org', 'sltrib.com', 'ecowatch.com', 'nypost.com']","[('A mink in Utah has tested positive for the contagion -- the first-ever known case in a wild animal, according to officials.', 0.7763041), ('Tom Koerner / USFWS A mink in Utah has become the first wild animal in the world to test positive for the new coronavirus, according to an alert sent out Sunday by the International Society for Infectious Diseases.', 0.7532228), ('A wild mink in Utah has become the first wild animal to test positive for COVID-19.', 0.6881078), ('On Sunday, the International Society for the Infectious Diseases sent out an alert saying a wild mink in Utah had tested positive.', 0.6759821), ('Reuters reported that a U.S. Department of Agriculture (USDA) notice indicated that a “free-ranging, wild mink” that later tested positive for the coronavirus was captured near a mink farm in Utah where cases of the virus have been reported among the resident population.', 0.6711977)]"
89,165,Genomic diversity of SARS-CoV-2 can be accelerated by a mutation in the nsp14 gene.,can,genomic diversity of sars-cov-2 cannot be accelerated by a mutation in the nsp14 gene.,https://www.biorxiv.org/content/10.1101/2020.12.23.424231v1,Preprint,0.999828577041626,21492,True,"['biorxiv.org', 'nih.gov', 'biorxiv.org', 'medrxiv.org', 'twitter.com']","[('Our results implicate nsp14 as a source of increased mutation rate in SARS-CoV-2 genomes.', 0.7564659), ('In this study, to understand genome evolution of SARS-CoV-2 in the current pandemic, we examined mutations of SARS-CoV-2 nsp14 which could inhibit its error-correcting function.', 0.72642714), ('SARS-CoV-2 nsp14, due to similar exonuclease activity, is therefore a potential modulator of host interactions, independent of its link to increased mutation load.', 0.6768131), ('(2020a) Eskier D, Karakulah G, Suner A, Oktay Y. RdRp mutations are associated with SARS-CoV-2 genome evolution.', 0.6557939), ('(A) The mutation density vs. time for the whole SARS-CoV-2 genome.', 0.6424775)]"
91,172,Mutations rise along with cases.,rise,mutations fall along with cases.,https://news.yahoo.com/covid-19-challenge-mutations-rise-060100868.html,General,0.9998282194137572,12,True,"['apnews.com', 'latimes.com', 'aljazeera.com', '13wham.com', 'yahoo.com']","[(""Story continues MUTATIONS ON THE RISE It's normal for viruses to acquire small changes or mutations in their genetic alphabet as they reproduce."", 0.5443092), ('MUTATIONS ON THE RISE It’s normal for viruses to acquire small changes or mutations in their genetic alphabet as they reproduce.', 0.5269998), ('In March 2020, a mutation called D614G emerged that made it more likely to spread.', 0.49116862), ('This would precipitate a wave of follow-on immigration.', 0.47993898), ('The coronavirus is becoming more genetically diverse, and health officials say the high rate of new cases is the main reason.', 0.42470258)]"
92,174,Tanzania to use local herbs instead of vaccine against Covid-19.,herbs,tanzania to use local vaccines instead of vaccine against covid-19.,https://www.africanews.com/2020/12/18/tanzania-to-use-local-herbs-instead-of-vaccine-against-covid-19/,Press Release,0.9998282194137572,32106,True,"['africanews.com', 'voanews.com', 'africanews.com', 'lse.ac.uk', 'medium.com']","[('Tanzania is among the first countries in Africa to order for the touted Madagascar Covid herb in the fights against the virus.', 0.7108275), ('The President and the Ministry of Health also advised people to use local herbs to treat COVID-19 symptoms, emphasising that the virus has neither cure nor vaccine.', 0.696517), ('The substance has proven effectiveness against malaria, but no clinical trials have tested it against COVID-19, either as a cure or as a preventative.', 0.6233343), ('Despite the fact that no one is certain whether reported symptoms are those of COVID-19 or other common illnesses, due to the absence of testing across the entire region, people in Lindi have been attributing the use of these local herbs to a reduction in the infection rate, and subsequent reduction in fear, creating new hope that the virus can be treated.', 0.6170341), ('A K says: November 15, 2020 at 7:32 am Great thinking on remedies for Covid-19 in Tanzania.', 0.6004054)]"
94,180,SARS-CoV-2 infection control implementation based on sources of infection showing directions for three age groups in Japan.,japan,sars-cov-2 infection control implementation based on sources of infection showing directions for three age groups in Canada.,https://www.medrxiv.org/content/10.1101/2021.01.14.21249637v1,Preprint,0.9998281002044678,25538,True,"['medrxiv.org', 'medrxiv.org', 'cdc.gov', 'aafp.org', 'who.int']","[('Methods and findings This retrospective observational case series study analyzed transmission patterns of real-time polymerase chain reaction (RT- PCR)-confirmed SARS-CoV-2 infections found by local health authorities and commercial laboratories during January 14 through July 31, 2020 in Japan.', 0.65979326), ('This report describes different SARS-CoV-2 transmission patterns by age group in Japan.', 0.655935), ('Three of the studies required that the children have a diagnosis of Kawasaki disease to be included; several required cardiovascular involvement or suspected cardiovascular involvement.', 0.57682085), ('It is not clear how they identified them, but 96 of these asymptomatic persons and 32 of their cabin mates who tested negative were transferred to a hospital in Japan for seven days of observation.', 0.5307035), ('They collected descriptions of each confirmed case from the local Municipal Health Commission website of 320 cities in mainland China, excluding Hubei province.', 0.5085581)]"
96,182,Treatment Study for Adults who tested positive for Coronavirus.,treatment,No study for adults who tested positive for coronavirus.,https://stopcovidtrial.wustl.edu/,Clinical,0.9998279809951782,8548,True,"['wustl.edu', 'clinicaltrials.gov', 'aafp.org', 'buffalo.edu', 'nih.gov']","[('Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.', 0.5952978), ('The drug has been shown to block infectivity of the novel coronavirus.', 0.5676125), ('Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study.', 0.5645432), ('Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020.', 0.55291045), ('Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.', 0.5504481)]"
99,189,Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape.,block,structure-guided multivalent nanobodies promote sars-cov-2 infection and suppress mutational escape.,https://science.sciencemag.org/content/early/2021/01/11/science.abe6230.full,Academic Report,0.99982750415802,3655,True,"['sciencemag.org', 'nih.gov', 'nih.gov', 'biorxiv.org', 'x-mol.com']","[('Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for SARS-CoV-2 Spike and picomolar neutralization of SARS-CoV-2 infection.', 0.7823237), ('Combinations of nanobodies that bound to independent epitopes were also more potent in preventing SARS-CoV-2 mNeonGreen replication in human cells (Fig.', 0.77766454), ('The structure-based multivalent nanobodies we present have strong potential clinical applications owing to increased neutralizing activity and in-built protection from rapid emergence of escape mutants.', 0.739905), ('We further validated virus neutralization microscopically by quantifying the replication of an mNeonGreen expressing clone of SARS-CoV-2 on human Caco2 cells in the presence of nanobodies over time (fig.', 0.7356416), ('Custódio, T.F., et al., Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2.', 0.7271725)]"
100,190,"Untangling factors associated with country-specific COVID-19 incidence , mortality and case fatality rates during the first quarter of 2020.",2020,"untangling factors associated with country-specific covid-19 incidence, mortality and case fatality rates during the first quarter of 2009.",https://www.medrxiv.org/content/10.1101/2020.04.22.20075580v1,Preprint,0.99982750415802,25538,True,"['medrxiv.org', 'researchgate.net', 'medrxiv.org', 'twitter.com', 'medrxiv.org']","[('Here we aim to untangle factors that are associated with the differences during the first quarter of the year 2020.', 0.6066941), ('Number of performed COVID-19 tests has a strong correlation with country- specific incidence (p < 2 × 10−16) and mortality rate (p = 5.1 × 10−8).', 0.58424157), ('We rank countries by COVID-19 mortality corrected for incidence and the factors that were shown to affect it, and by CFR corrected for outbreak duration, yielding very similar results.', 0.5719093), ('Country hemisphere demonstrated significant correlation only with mortality (p = 0.17 and 0.036) whereas population density (p = 0.94 and p = 0.75) and latitude (p = 0.61 and 0.059) did not reach significance in our model.', 0.54357326), ('10.1101/2020.04.28.066951 -- Posted: 2020-04-29 Discussion: Onsite Evaluation of 19 antiviral drugs against SARS-CoV-2 Infection Liu, S., Lien, C., Selveraj, P., Wang, T. 10.1101/2020.04.29.067983 -- Posted: 2020-04-29 Controlling the SARS-CoV-2 outbreak, insights from large scale whole genome sequences generated across the world Phelan, J., Deelder, W., Ward, D., Campino, S., Hibberd, M. L., Clark, T. G. 10.1101/2020.04.28.066977 -- Posted: 2020-04-29 State-by-State prediction of likely COVID-19 scenarios in the United States and assessment of the role of testing and control measures Zhai, Z.-M., Long, Y.-S., Kang, J., Li, Y.-L., Zeng, L., Han, L.-L., Lin, Z.-H., Zeng, Y.-Q., Wu, D.-Y., Tang, M., Xu, D., Liu, Z., Lai, Y.-C. 10.1101/2020.04.24.20078774 -- Posted: 2020-04-29 A gene locus that controls expression of ACE2 in virus infection Ansari, M. A., Marchi, E., Ramamurthy, N., Aschenbrenner, D., Hackstein, C.-P., STOP-HCV consortium, , ISARIC-4C Investigators, , Bowden, R., Sharma, E., Pedergnana, V., Venkateswaran, S., Kugathasan, S., Mo, A., Gibson, G., McLauchlan, J., Barnes, E., Baillie, J. K., Teichmann, S., Mentzer, A., Todd, J., Knight, J., Uhlig, H., Klenerman, P. 10.1101/2020.04.26.20080408 -- Posted: 2020-04-29 The natural history and transmission potential of asymptomatic SARS-CoV-2 infection Chau, N. V. V., Lam, V. T., Dung, N. T., Yen, L. M., Minh, N. N. Q., Hung, L. M., Ngoc, N. M., Dung, N. T., Man, D. N. H., Nguyet, L. A., Nhat, L. T. H., Nhu, L. N. T., Ny, N. T. H., Hong, N. T. T., Kestelyn, E., Dung, N. T. P., Phong, N. T., Xuan, T. C., Hien, T. T., Tu, T. N. H., Geskus, R. B., Thanh, T. T., Truong, N. T., Binh, N. T., Thuong, T. C., Thwaites, G., Tan, L. V. 10.1101/2020.04.27.20082347 -- Posted: 2020-04-29 Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China Feng, X., Li, P., Ma, L., Liang, H., Lei, J., Li, W., Wang, K., Song, Y., Li, S., Yang, W., Yang, C. 10.1101/2020.04.24.20078063 -- Posted: 2020-04-29 Collection RSS ', 0.43338853)]"
102,194,Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro.,inhibit,berberine and obatoclax induce sars-cov-2 replication in primary human nasal epithelial cells in vitro.,https://www.biorxiv.org/content/10.1101/2020.12.23.424189v1,Preprint,0.9998270869255066,21492,True,"['biorxiv.org', 'researchgate.net', 'biorxiv.org', 'bvsalud.org', 'europepmc.org']","[('Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial c ', 0.9445452), ('Moreover, both obatoclax and berberine inhibited SARS-CoV-2 replication in these primary target cells.', 0.84780383), ('We assessed infection of primary human nasal epithelial cells cultured on an air-liquid interface and found that SARS-CoV-2 infection induced and repressed expression of a specific set of cytokines and chemokines.', 0.7087951), ('In this study, we demonstrate that berberine and obatoclax, two broad-spectrum antiviral compounds, are effective against multiple isolates of SARS-CoV-2.', 0.7055528), ('Berberine, a plant-derived alkaloid, inhibited SARS-CoV-2 at low micromolar concentrations and obatoclax, originally developed as an anti-apoptotic protein antagonist, was effective at sub-micromolar concentrations.', 0.6901146)]"
104,197,Vascular brain pathology is more important than neurodegeneration in the pathogenesis of pre-stroke cognitive impairment.,more,vascular brain pathology is less important than neurodegeneration in the pathogenesis of pre-stroke cognitive impairment.,https://www.medrxiv.org/content/10.1101/2020.06.12.20129106v1,Preprint,0.999826967716217,25538,True,"['medrxiv.org', 'researchgate.net', 'medrxiv.org', 'nih.gov', 'twitter.com']","[('Share Vascular brain pathology is more important than neurodegeneration in pathogenesis of pre-stroke cognitive impairment T Schellhorn, M Zucknick, T Askim, R Munthe-Kaas, H Ihle-Hansen, YM Seljeseth, AB Knapskog, H Næss, H Ellekjær, P Thingstad, T Bruun Wyller, I Saltvedt, MK Beyer medRxiv 2020.06.12.20129106; doi: https://doi.org/10.1101/2020.06.12.20129106 Share This Article: Copy Citation Tools Vascular brain pathology is more important than neurodegeneration in pathogenesis of pre-stroke cognitive impairment T Schellhorn, M Zucknick, T Askim, R Munthe-Kaas, H Ihle-Hansen, YM Seljeseth, AB Knapskog, H Næss, H Ellekjær, P Thingstad, T Bruun Wyller, I Saltvedt, MK Beyer medRxiv 2020.06.12.20129106; doi: https://doi.org/10.1101/2020.06.12.20129106 ', 0.8268627), ('Understanding the pathology of vascular cognitive impairment.', 0.7418966), ('Cerebrovascular pathology was the dominating imaging finding associated with cognitive impairment, thus indicating that the pathogenesis of pre-stroke cognitive impairment might be driven more by small vessel disease (SVD) than neurodegenerative changes.', 0.7411772), ('Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well.', 0.68645155), ('Cognitive impairment of vascular origin: neuropathology of cognitive impairment of vascular origin.', 0.6739892)]"
106,201,US approves Moderna as second vaccine.,vaccine,us approves moderna as second state.,https://www.bbc.com/news/world-us-canada-55370999,Vaccine Research,0.999826729297638,85,True,"['bbc.com', 'cnbc.com', 'fda.gov', 'euronews.com', 'huffpost.com']","[('Both the new Moderna vaccine and the Pfizer-BioNTech shot require two doses several weeks apart.', 0.704592), (""VIDEO2:0202:02 FDA approves Moderna vaccine for emergency use The News with Shepard Smith The Food and Drug Administration has approved Moderna's coronavirus vaccine for emergency use."", 0.6567832), (""Moderna's Covid vaccine is its first-ever FDA authorized product."", 0.65572095), (""The vaccine — the second approved for use in the U.S. behind Pfizer and BioNTech's — bolsters the U.S. supply of doses."", 0.6097681), ('Like the Pfizer jab, the Moderna vaccine also requires a second booster shot.', 0.6060833)]"
111,213,Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection.,can,detection of sars-cov-2 nucleocapsid antigen from serum cannot aid in timing of covid-19 infection.,https://www.medrxiv.org/content/10.1101/2021.01.08.20248771v1,Preprint,0.9998252987861632,25538,True,"['medrxiv.org', 'medrxiv.org', 'corelaboratory.abbott', 'labcorp.com', 'nih.gov']","[('Our results suggest that SARS-CoV-2 N-antigenemia may be used as a diagnostic marker in acute COVID-19.', 0.83628243), ('Specific IgM antibodies to SARS- CoV-2 may be detectable in COVID-19 patients during the symptomatic phase of the disease.', 0.81293505), ('The combination of simultaneous SARS-CoV-2 antigen and antibody testing appeared to provide useful information for the timing of COVID-19.', 0.7907794), ('--- Qualitative detection of high affinity antibodies to SARS-CoV-2 nucleocapsid (N) protein, the virus that causes COVID-19, to aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.', 0.78901434), ('Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives, Clinical Microbiology and Infection , 2020].', 0.78643227)]"
112,214,COVID-19 Trends Among Persons Aged 0–24 Years.,years,covid-19 trends among persons aged 0–24 months.,https://www.cdc.gov/mmwr/volumes/70/wr/mm7003e1.htm,Government Agency,0.9998252987861632,529,True,"['cdc.gov', 'washington.edu', 'cdc.gov', 'tephiconnect.org', 'idsociety.org']","[('COVID-19 trends among school-aged children--United States, March 1-September 19, 2020.', 0.7165708), ('During March 1–December 12, 2020, a total of 2,871,828 laboratory- confirmed cases of COVID-19 in young people aged 0–24 years were reported in the United States, with the majority (57%) occurring among those aged 18–24 years.', 0.57474196), ('; CDC COVID-19 Response Team.', 0.5634961), ('COVID-19 weekly incidence, ,† by age group -- United States, March 1-December 12, 2020§ Abbreviation: COVID-19 = coronavirus disease 2019.', 0.5618346), ('COVID-19 case data for all confirmed cases were analyzed to examine demographic characteristics, underlying health conditions,† and outcomes.', 0.5525092)]"
113,215,The COVID-19 response in the United States seems like a tool for class and ethnic cleansing.,cleansing,the covid-19 response in the united states seems like a tool for class and ethnic research.,https://vishalpsingh.medium.com/the-covid-19-response-in-the-united-states-can-be-described-as-a-tool-for-class-and-ethnic-cf8a74554f0e,General,0.9998249411582948,99,True,"['crisisgroup.org', 'medium.com', 'cfr.org', 'history.com', 'brookings.edu']","[('Source: Los Angeles County Public Health LOS ANGELES — Let’s hope everyone has seen the COVID-19 death rate breakdown by ethnicity and poverty level in Los Angeles County.', 0.57267094), ('We can also see how increase in poverty surroundings has a dramatic correlation to higher death rates from COVID-19.', 0.55553746), ('have zero to little risk….so we use them to develop herd… > we want them infected… ” If this country ISN’T trying to weaponize the COVID-19 response in order to inflict higher death rates upon minorities and people living in poverty, it’s certainly an interesting coincidence that this outcome just happens to be the actual impact their response seems to have.', 0.529344), ('Using this definition, Bell-Fialkoff and many observers of history consider the aggressive displacement of Native Americans by European settlers in North America in the 18th and 19th centuries to be ethnic cleansing.', 0.51397103), ('In this way, despite controversy over its exact definition, ethnic cleansing is now clearly covered under international law, though efforts to prevent and punish acts of ethnic cleansing (such as those in Darfur) are still in development.', 0.49274248)]"
114,216,Nearly half a million people may have had COVID-19 in Wuhan.,million,nearly half a 100 people may have had covid-19 in wuhan.,https://www.cnn.com/2020/12/29/asia/china-coronavirus-seroprevalence-study-intl-hnk/index.html,Epidemiology,0.9998249411582948,64,True,"['cnn.com', 'dailymail.co.uk', 'theguardian.com', 'twitter.com', 'voanews.com']","[('Advertisement Read more: In Wuhan, nearly half a million people may have had Covid-19, study shows.', 0.8374324), ('As of Sunday, Wuhan had reported a total of 50,354 confirmed cases of Covid-19, according to the Wuhan Municipal Health Commission.', 0.5959004), ('That study estimated more than 232,000 people may have been infected in the first wave of Covid-19 in mainland China, four times the official figures.', 0.58982515), ('The figures suggest the previously unknown respiratory disease, labeled by international health officials as COVID-19, has considerable capacity to spread far beyond the 59,804 cases confirmed in China as of Thursday.', 0.56699574), (""China's CDC said the study had been conducted a month after China 'contained the first wave of the Covid-19 epidemic' and that it revealed a much higher prevalence rate found among Wuhan residents."", 0.5391967)]"
116,218,NIH ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients.,pauses,nih activ trial of blood thinners allowed enrollment of critically ill covid-19 patients.,https://www.nih.gov/news-events/news-releases/nih-activ-trial-blood-thinners-pauses-enrollment-critically-ill-covid-19-patients,Government Agency,0.9998247027397156,136,True,"['nih.gov', 'nih.gov', 'usnews.com', 'cbp.gov', 'nihr.ac.uk']","[('Informed by the deliberations of these oversight boards, all the trial sites have paused enrollment of the most critically ill hospitalized patients with COVID-19.', 0.7547444), ('Informed by the deliberations of these oversight boards, all of the trial sites have paused enrollment of the most critically ill hospitalised patients with COVID-19.', 0.74745315), ('Coronavirus Patients Is Halted Giving anticoagulants to hospitalized Covid-19 patients is routine.', 0.6823414), ('Whether the use of full-dose compared to low-dose blood thinners leads to better outcomes in hospitalized patients with less COVID-19 severe disease remains a very important question.', 0.66939515), ('The trials are continuing to enroll moderately ill hospitalised COVID-19 patients.', 0.6328296)]"
117,220,North American deer mice are susceptible to SARS-CoV-2.,susceptible,north american deer mice are resistant to sars-cov-2.,https://www.biorxiv.org/content/10.1101/2020.07.25.221291v1.full,Preprint,0.9998244643211364,21492,True,"['biorxiv.org', 'nih.gov', 'europepmc.org', 'news-medical.net', 'washingtonpost.com']","[('SARS-CoV-2 infection and transmission possible in North American deer mice.', 0.91753787), ('""SARS-CoV-2 infection and transmission possible in North American deer mice"".', 0.9086039), ('SARS-CoV-2 transmission in deer mice.', 0.8958124), ('(A) Transient weight loss occurred in some deer mice inoculated with SARS-CoV-2.', 0.80446327), ('Bao L. et al., The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.', 0.7563809)]"
122,238,Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.,drive,recurrent deletions in the sars-cov-2 spike glycoprotein prevent antibody escape.,https://www.biorxiv.org/content/10.1101/2020.11.19.389916v2,Preprint,0.9998229146003724,21492,True,"['biorxiv.org', 'europepmc.org', 'biorxiv.org', 'news-medical.net', 'medrxiv.org']","[('Natural deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.', 0.96560824), ('Thus, whether in single RDRs or between pairs of RDRs, the occurrence of recurrent deletions associated with distinct epitopes, leading to the abolition of binding, but allowing the protein to retain its function, shows the change in antigenicity between natural SARS-CoV-2 variants.', 0.7702843), ('Share Natural deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape Kevin R. McCarthy, Linda J. Rennick, Sham Nambulli, Lindsey R. Robinson- McCarthy, William G. Bain, Ghady Haidar, W. Paul Duprex bioRxiv 2020.11.19.389916; doi: https://doi.org/10.1101/2020.11.19.389916 Share This Article: Copy Citation Tools Natural deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape Kevin R. McCarthy, Linda J. Rennick, Sham Nambulli, Lindsey R. Robinson- McCarthy, William G. Bain, Ghady Haidar, W. Paul Duprex bioRxiv 2020.11.19.389916; doi: https://doi.org/10.1101/2020.11.19.389916 ', 0.76992434), ('You are going to email the following Natural deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.', 0.74452806), ('These data reveal strong positive selection on SARS-CoV-2 during convalescent plasma therapy and identify the combination of Spike mutations D796H and Δ H69/ Δ V70 as a broad antibody resistance mechanism against commonly occurring antibody responses to SARS-CoV-2.', 0.72116655)]"
123,239,MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease.,inhibit,mva vector vaccines promote sars cov-2 replication in upper and lower respiratory tracts of transgenic mice and prevent lethal disease.,https://www.biorxiv.org/content/10.1101/2020.12.30.424878v1,Preprint,0.9998227953910828,21492,True,"['biorxiv.org', 'nih.gov', 'biorxiv.org', 'news-medical.net', 'twitter.com']","[('In a transgenic mouse model, one or two injections of recombinant MVAs that express modified forms of S inhibited CoV-2 replication in the upper and lower respiratory tracts and prevented severe disease.', 0.7652252), ('Intramuscular injection of mice with the rMVAs induced S-binding and pseudovirus-neutralizing antibodies.', 0.74893844), ('The researchers found that serum from mice vaccinated with MVA that expressed wildtype S could be given intraperitoneally to transgenic hACE2-expressing mice, producing a high neutralizing titer.', 0.74595416), ('A recent paper, that appeared as a preprint on the bioRxiv server in January 2021, shows the effectiveness of a novel recombinant vaccinia virus that expresses modified SARS-CoV-2 spike antigen, in preventing the replication of the virus in the respiratory tract of transgenic mice, and to prevent lethal disease.', 0.7313552), ('Weight loss and lethality following intranasal infection of transgenic hACE2 mice with CoV-2 was prevented by one or two immunizations with rMVAs or by passive transfer of serum from vaccinated mice.', 0.73005176)]"
124,240,The cellular immune response to COVID-19 deciphered by single cell multi-omics across three UK centres.,three,the cellular immune response to covid-19 deciphered by single cell multi-omics across two uk centres.,https://www.medrxiv.org/content/10.1101/2021.01.13.21249725v1,Preprint,0.9998227953910828,25538,True,"['medrxiv.org', 'researchgate.net', 'medrxiv.org', 'biorxiv.org', 'cshlp.org']","[('To characterise the systemic host immune response to SARS-CoV-2, we performed single-cell RNA- sequencing coupled with analysis of cell surface proteins, providing molecular profiling of over 800,000 peripheral blood mononuclear cells from a cohort of 130 patients with COVID-19.', 0.66813135), ('Together, these data detail the cellular processes present in peripheral blood during an acute immune response to COVID-19, and serve as a template for multi-omic single cell data integration across multiple centers to rapidly build powerful resources to help combat diseases such as COVID-19.', 0.58567506), ('Our cohort, from three UK centres, spans the spectrum of clinical presentations and disease severities ranging from asymptomatic to critical.', 0.57526046), ('Full single cell transcriptomes coupled with quantification of 188 cell surface proteins, and T and B lymphocyte antigen receptor repertoires have provided several insights into COVID-19: 1. a new non-classical monocyte state that sequesters platelets and replenishes the alveolar macrophage pool; 2. platelet activation accompanied by early priming towards megakaryopoiesis in immature haematopoietic stem/progenitor cells and expansion of megakaryocyte-primed progenitors; 3. increased clonally expanded CD8+ effector:effector memory T cells, and proliferating CD4+ and CD8+ T cells in patients with more severe disease; and 4. relative increase of IgA plasmablasts in asymptomatic stages that switches to expansion of IgG plasmablasts and plasma cells, accompanied with higher incidence of BCR sharing, as disease severity increases.', 0.56708443), ('Three control groups were included: healthy volunteers, patients suffering from a non-COVID-19 severe respiratory illness and healthy individuals administered with intravenous lipopolysaccharide to model an acute inflammatory response.', 0.54663825)]"
125,242,More Things to Do With mRNA.,mrna,more things to do with work.,https://blogs.sciencemag.org/pipeline/archives/2021/01/12/more-things-to-do-with-mrna,Academic Comment,0.9998225569725036,3655,True,"['sciencemag.org', 'modernatx.com', 'cnn.com', 'cdc.gov', 'mercurynews.com']","[('At Moderna, we are leveraging the fundamental role that mRNA plays in protein synthesis.', 0.6871606), ('The Science of mRNA Our mRNA Platform Research Engine Early Development Engine Intellectual Property ', 0.64907366), ('Using mRNA as a drug opens up a breadth of opportunities to treat and prevent disease.', 0.63678324), ('We deliver the mRNA sequence to the cells responsible for making that protein via one of several modalities.', 0.6220266), ('Skip to main content Moderna, Inc. mRNA Technology The Science of mRNA Our mRNA Platform Research Engine Early Development Engine Intellectual Property COVID-19 Resources USA site for EUA Global Site and Resources Publications and External Resources Pipeline Therapeutic Areas Clinical Trials Modalities Citizenship About Us Leadership Key Milestones Quick Facts Strategic Collaborators New Venture Labs Publications Newsroom Investors Blog Careers Contact Us ', 0.55993676)]"
127,249,CDC says new Covid strain in UK could already be circulating undetected in U.S .,already,cdc says new covid strain in uk could not be circulating undetected in u.s.,https://www.cnbc.com/2020/12/22/cdc-says-new-covid-strain-in-uk-could-already-be-circulating-undetected-in-us.html,General,0.9998217225074768,239,True,"['cnbc.com', 'news4jax.com', 'cnbc.com', 'clickondetroit.com', 'nbcphiladelphia.com']","[('""Given the small fraction of US infections that have been sequenced, the variant could already be in the United States without having been detected.""', 0.5290393), ('The new coronavirus ""mutates regularly,"" the CDC noted, but the overwhelming majority of mutations are insignificant.', 0.4907092), ('The CDC said it doesn\'t know why the new strain of the virus emerged, but it could have been ""by chance alone.""', 0.47081274), ('The significance of the new variant found first in the U.K. has yet to be determined, but the CDC noted that based on early data from the U.K., the new strain could ""potentially be more rapidly transmissible than other circulating strains.""', 0.4492302), (""While the variant hasn't been found in the U.S. yet, the CDC noted that scientists haven't sequenced the genetic coding for many Covid-19 infections here."", 0.43657273)]"
129,255,Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model .,prevents,inactivated rabies virus vectored sars-cov-2 vaccine causes disease in a syrian hamster model.,https://www.biorxiv.org/content/10.1101/2021.01.19.427373v1,Preprint,0.99982088804245,21492,True,"['biorxiv.org', 'biorxiv.org', 'medrxiv.org', 'reddit.com', 'nature.com']","[('Here we further evaluated an inactivated rabies vectored SARS-CoV-2 S1 vaccine CORAVAX in a Syrian hamster model.', 0.89724433), ('Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2.', 0.7491017), ('Development of an inactivated vaccine candidate for SARS-CoV-2.', 0.7267802), ('Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.', 0.70669514), ('Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials.', 0.70645463)]"
131,262,Suspicions grow that nanoparticles in Pfizer 's COVID-19 vaccine trigger rare allergic reactions.,rare,suspicions grow that nanoparticles in pfizer's covid-19 vaccine trigger systemic allergic reactions.,https://www.sciencemag.org/news/2020/12/suspicions-grow-nanoparticles-pfizer-s-covid-19-vaccine-trigger-rare-allergic-reactions,Vaccine Research,0.9998190999031068,3655,True,"['sciencemag.org', 'twitter.com', 'reddit.com', 'mashupmd.com', 'raps.org']","[('Severe allergy-like reactions in at least eight people who received the COVID-19 vaccine produced by Pfizer and BioNTech over the past 2 weeks may be due to a compound in the packaging of the messenger RNA (mRNA) that forms the vaccine’s main ingredient, scientists say.', 0.6801218), ('“This is new.” News reports about the allergic reactions have already created anxiety.', 0.6019527), ('Some allergists and immunologists believe a small number of people previously exposed to PEG may have high levels of antibodies against PEG, putting them at risk of an anaphylactic reaction to the vaccine.', 0.5737363), ('NIAID is also setting up a study in collaboration with FDA to analyze the response to the vaccine in people who have high levels of anti-PEG antibodies or have experienced severe allergic responses to drugs or vaccines before.', 0.5658521), ('“Patients with severe allergies in the US are getting nervous about the possibility that they may not be able to get vaccinated, at least with those two vaccines,” Togias wrote in an invitation to meeting participants.', 0.557871)]"
133,267,Epidemiologist looks to the past to predict second post-pandemic 'roaring 20s '.,past,epidemiologist looks to the goal to predict second post-pandemic 'roaring 20s '.,https://www.theguardian.com/world/2020/dec/21/epidemiologist-1918-flu-pandemic-roaring-20s-post-covid,General,0.9998177886009216,146,True,"['theguardian.com', 'independent.co.uk', 'dailymail.co.uk', 'twitter.com', 'pinterest.com']","[('“It’s miraculous.” Then, once pandemics end, often there is a period in which people seek out extensive social interaction, and which Christakis predicts will be a second “roaring 20s” just as after the 1918 flu pandemic.', 0.55030376), ('Photograph: Apu Gomes/AFP/Getty Images Dr Nicholas Christakis says once pandemics end, often there is a period in which people seek out extensive social interactions Jessica Glenza @JessicaGlenza Mon 21 Dec 2020 03.00 EST Last modified on Mon 21 Dec 2020 13.05 EST It is almost exactly one year since the coronavirus Sars-CoV-2 was identified by Chinese scientists as the source of a new, lethal respiratory illness.', 0.42368627), ('He projects that the coronavirus pandemic will be no different, with the world experiencing an economic and social revival rivaling that which followed the 1918 flu pandemic by the year 2024.', 0.41322964), (""Dr Nicholas Christakis, a social epidemiologist who specializes in behavior patterns, put forward his prediction for life after the pandemic in his new book Apollo's Arrow: The Profound and Enduring Impact of Coronavirus on the Way We Live."", 0.4125864), ('However he said that many of the hardships brought by the pandemic were inevitable, based on his studies of similar crises in history.', 0.41241023)]"
135,269,China is guarding ancient bat caves against journalists and scientists seeking to discover the origins of the coronavirus.,china,WHO is guarding ancient bat caves against journalists and scientists seeking to discover the origins of the coronavirus.,https://www.businessinsider.com/china-policing-bat-caves-scientists-hope-coronavirus-clues-inside-2020-12,General,0.9998170733451844,233,True,"['yahoo.com', 'yahoo.com', 'businessinsider.in', 'businessinsider.com', 'reddit.com']","[('China is guarding ancient caves where bats infected with coronavirus variants once lived in an attempt to control research into the outbreak, The Associated Press reported.', 0.8201914), ('The caves in Yunnan Province, south China, are where scientists hope to find evidence of how the coronavirus evolved in bats.', 0.68597233), ('Advertisement But China is taking steps to safeguard the site and control who gets access, The AP said, adding that a team of its journalists were tailed by security services and refused entry into one of the caves.', 0.6559931), ('But China is taking steps to safeguard the site and control who gets access, The AP said, adding that a team of its journalists were tailed by security services and refused entry into one of the caves.', 0.6455044), (""The caves, located in China's southern Yunnan Province, are thought to hold the key to understanding how the novel coronavirus evolved in bats."", 0.6225053)]"
137,273,China raises alarm after 63 local infections found in Hebei province on one day.,day,china raises alarm after 63 local infections found in hebei province on one month.,https://www.scmp.com/news/china/science/article/3116597/coronavirus-china-raises-alarm-after-63-local-infections-found,General,0.9998162388801576,2712,True,"['scmp.com', 'yahoo.com', 'yahoo.com', 'twitter.com', 'reddit.com']","[('The 63 infections – identified on Tuesday and announced on Wednesday – prompted a top Chinese Centre for Disease Control and Prevention (CDC) official to warn that the tally might rise further in the coming days.', 0.6247316), ('> The first identified case of the outbreak was a 61-year-old woman in > Xiaoguozhuang who was confirmed to be infected on Saturday.', 0.49554646), ('China is on high alert for imported cases, with several cities stepping up their precautions.', 0.47390282), ('More from South China Morning Post: Coronavirus: China says it can produce 1 billion doses of a Sinopharm vaccine this year China’s first case of new coronavirus strain is no cause for alarm, says infectious disease expert Coronavirus: China ‘must detect asymptomatic cases’ to prevent Lunar New Year spread China on alert for new coronavirus strain but flights from Britain continue This article Coronavirus: Chinese city in lockdown as Hebei province has biggest outbreak in months first appeared on South China Morning Post For the latest news from the South China Morning Post download our mobile app.', 0.46998414), ('Get the latest insights and analysis from our Global Impact newsletter on the big stories originating in China.', 0.406301)]"
138,274,Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.,adults,early high-titer plasma therapy to prevent severe covid-19 in older infants.,https://www.nejm.org/doi/full/10.1056/NEJMoa2033700,Academic Report,0.9998162388801576,12635,True,"['nejm.org', 'nih.gov', 'nejm.org', 'medrxiv.org', 'acc.org']","[('Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.', 0.76942194), ('Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial.', 0.7590871), ('Early safety indicators of COVID-19 convalescent plasma in 5000 patients.', 0.73474485), ('Conclusions: Early administration of high-titer convalescent plasma against SARS-CoV-2 to mildly ill infected older adults reduced the progression of Covid-19.', 0.7136195), ('A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19.', 0.70731413)]"
139,275,"Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease , United States.",states,"pathology and pathogenesis of sars-cov-2 associated with fatal coronavirus disease, united worldwide.",https://wwwnc.cdc.gov/eid/article/26/9/20-2095_article,General,0.9998158812522888,529,True,"['nih.gov', 'medscape.com', 'cdc.gov', 'researchgate.net', 'elsevierpure.com']","[('Figure 2 Histopathologic findings associated with underlying… Figure 2 Histopathologic findings associated with underlying conditions in fatal coronavirus disease.', 0.82051677), ('A) Patient no.… Figure 2 Histopathologic findings associated with underlying conditions in fatal coronavirus disease.', 0.8040387), ('SARS-CoV-2 belongs to the group of betacoronaviruses that includes severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS- CoV), which can infect the lower respiratory tract and cause a severe and fatal respiratory syndrome in humans.', 0.7267834), ('Immunostaining of severe acute respiratory syndrome coronavirus 2 in pulmonary tissues from fatal coronavirus disease cases.', 0.7065933), ('An ongoing pandemic of coronavirus disease (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).', 0.6948433)]"
140,276,Formulation of a composite nasal spray enabling enhanced surface coverage and prophylaxis of SARS-COV-2.,nasal,formulation of a composite water spray enabling enhanced surface coverage and prophylaxis of sars-cov-2.,https://www.biorxiv.org/content/10.1101/2020.11.18.388645v1,Preprint,0.9998158812522888,21492,True,"['biorxiv.org', 'europepmc.org', 'biorxiv.org', 'news-medical.net', 'bvsalud.org']","[('Formulation of a composite nasal spray enabling enhanced surface coverage and prophylaxis ', 0.8857298), ('Carrageenan-based composite nasal spray may help prevent SARS-CoV-2 infection.', 0.81133294), ('If approved for use, the nasal spray could potentially help mitigate SARS-CoV-2 infection and transmissibility.', 0.80317605), ('""Carrageenan-based composite nasal spray may help prevent SARS-CoV-2 infection"".', 0.7995156), ('> ""This study has demonstrated the formulation of a potent antiviral nasal > spray, with not only prophylactic capacity, but the ability to prevent viral > transmission.', 0.7365705)]"
141,280,Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients.,adaptive,No immune responses to sars-cov-2 in recovered severe covid-19 patients.,https://www.medrxiv.org/content/10.1101/2021.01.05.20249027v1,Preprint,0.9998140931129456,25538,True,"['medrxiv.org', 'nature.com', 'nih.gov', 'cell.com', 'sciencemag.org']","[('Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals.', 0.859223), ('Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases.', 0.8296423), ('Sequencing and functional data revealed SARS-CoV-2-specific T-cell immune memory in the convalescent COVID-19 patients.', 0.8279071), ('1 Characterization of T- and B-cell immune repertoires in COVID-19 convalescent patients.', 0.8008988), ('Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.', 0.79467106)]"
142,282,Johnson & Johnson Announces Its First Phase 3 COVID-19 Vaccine Trial ENSEMBLE is Fully Enrolled.,first,johnson & johnson announces its final phase 3 covid-19 vaccine trial ensemble is fully enrolled.,https://www.jnj.com/our-company/johnson-johnson-announces-its-first-phase-3-covid-19-vaccine-trial-ensemble-is-fully-enrolled,Press Release,0.9998125433921814,13761,True,"['jnj.com', 'marketscreener.com', 'jnj.com', 'whbl.com', 'cmlviz.com']","[('“With our vaccine candidate now in our global Phase 3 trial, we are one step closer to finding a solution for COVID-19.', 0.7647678), ('Phase 3 Trial (ensemble) of Investigational Janssen Covid-19 Single-dose Vaccine Candidate is Fully Enrolled With About 45,000 Participants.', 0.7443377), ('Learn More Our Company Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S NEW BRUNSWICK, N.J., September 23, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi- country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.', 0.7276087), ('111 The large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) of the investigational Janssen COVID-19 single-dose vaccine candidate is now fully enrolled with approximately 45,000 participants.', 0.712819), ('Johnson & Johnson will develop and test its COVID-19 vaccine candidate in accordance with high ethical standards and sound scientific principles.', 0.6874939)]"
149,292,Low vitamin K status predicts mortality in a cohort of 138 hospitalized patients with COVID-19.,mortality,low vitamin k status predicts survival in a cohort of 138 hospitalized patients with covid-19.,https://www.medrxiv.org/content/10.1101/2020.12.21.20248613v1,Preprint,0.9998098015785216,25538,True,"['medrxiv.org', 'researchgate.net', 'medrxiv.org', 'europepmc.org', 'bvsalud.org']","[('Low vitamin K status predicts mortality in a cohort of 138 hospitalized patients with COVI ', 0.92954624), ('In conclusion, we found that low Vitamin K status predicted mortality in patients with COVID-19 supporting a potential role of Vitamin K in COVID-19.', 0.70568514), ('We aimed to test the hypothesis that low vitamin K status is a common characteristic of patients hospitalized with COVID-19 compared to population controls; and that low vitamin K status predicts mortality in COVID-19 patients.', 0.70194423), ('In a cohort of 138 COVID-19 patients and 140 population controls, we measured plasma dephosphorylated-uncarboxylated Matrix Gla Protein (dp-ucMGP), which reflects the functional Vitamin K status in peripheral tissue.', 0.6227683), ('In patients, levels of dp-ucMGP differed significantly between survivors (mean 877; 95% CI 778; 995) and non-survivors (mean 1445; 95% CI 1148; 1820).', 0.36230907)]"
154,305,NHS patients to receive life-saving COVID-19 treatments that could cut hospital time by 10 days.,days,nhs patients to receive life-saving covid-19 treatments that could cut hospital time by 10 years.,https://www.gov.uk/government/news/nhs-patients-to-receive-life-saving-covid-19-treatments-that-could-cut-hospital-time-by-10-days,Press Release,0.9998051524162292,681,True,"['www.gov.uk', 'wired-gov.net', 'reddit.com', 'thepharmaletter.com', 'bbc.com']","[('Patients in intensive care units across the UK are to receive potentially life-saving treatments for COVID-19 Government ensures life-saving drugs will be available in NHS healthcare settings with immediate effect Patients across the UK who are admitted to intensive care units due to COVID-19 are set to receive new life-saving treatments which can reduce the time spent in hospital by up to 10 days, the government has announced yesterday (Thursday 7 January).', 0.8577037), ('Published 7 January 2021 From: Department of Health and Social Care Patients in intensive care units across the UK are to receive potentially life-saving treatments for COVID-19 Government ensures life-saving drugs will be available in NHS healthcare settings with immediate effect Patients across the UK who are admitted to intensive care units due to COVID-19 are set to receive new life-saving treatments which can reduce the time spent in hospital by up to 10 days, the government has announced today (Thursday 7 January).', 0.7782055), ('Tocilizumab will be used to further reduce mortality from COVID-19 and in addition to dexamethasone, which is already standard of care for hospitalised patients receiving supplemental oxygen.', 0.6556344), ('Updated guidance will be issued tomorrow by the government and the NHS to trusts across the UK, encouraging them to use tocilizumab in their treatment of COVID-19 patients who are admitted to intensive care units, effective immediately.', 0.60501015), ('For patients needing oxygen, it cut the risk of death from 25% to 20%.', 0.597149)]"
155,306,COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and may be modified by dexamethasone.,may,covid-19 ards is characterized by a dysregulated host response that differs from cytokine storm and cannot be modified by dexamethasone.,https://www.medrxiv.org/content/10.1101/2020.12.28.20248552v1,Preprint,0.9998041987419128,25538,True,"['medrxiv.org', 'bvsalud.org', 'researchsquare.com', 'x-mol.com', 'docwirenews.com']","[('COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine ', 0.8218173), ('In summary, assessment of host gene expression in the lower airways of patients with COVID-19 ARDS did not demonstrate cytokine storm but instead revealed a unique and dysregulated host response predicted to be modified by dexamethasone.', 0.71681416), ('COVID-19 ARDS was characterized by a dysregulated host response with increased PTEN signaling and elevated expression of genes with non-canonical roles in inflammation and immunity that were predicted to be modulated by dexamethasone and granulocyte colony stimulating factor.', 0.71252626), ('In contrast to a cytokine storm, we observed reduced proinflammatory gene expression in COVID-19 ARDS when compared to ARDS due to other causes.', 0.7009592), ('Compared to other viral ARDS, COVID-19 was characterized by impaired interferon-stimulated gene expression.', 0.681383)]"
157,309,COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests.,two,covid-19 seroprevalence among healthcare workers of a large covid hospital in rome reveals strengths and limits of three different serological tests.,https://www.medrxiv.org/content/10.1101/2021.01.08.21249445v1,Preprint,0.9998039603233336,25538,True,"['medrxiv.org', 'twitter.com', 'medrxiv.org', 'medrxiv.org', 'biorxiv.org']","[('Seroprevalence was 3.66% using the POC test and 1.19% using venous blood test, with a significant difference between the two (p < 0.05).', 0.49111295), ('Since Fondazione Policlinico Universitario A. Gemelli (FPG) IRCCS has been enlisted as a COVID hospital, healthcare workers deployed to COVID wards were separated from those with limited or no exposure, whereas administrative staff was destined to work-from-home.', 0.47335345), ('Among low-risk population, point-of-care’s predictive values were 58.33% (positive) and 98.23% (negative) whereas venous blood test’s were 92.86% (positive) and 98.53% (negative).', 0.43746293), ('POC sensitivity and specificity were, respectively, 63.64% (95% confidence interval (CI): 62.20% to 65.04%) and 96.64% (95% CI: 96.05% to 97.13%), while those of the venous blood test were, respectively, 78.79% (95% CI: 77.58% to 79.94%) and 99.36% (95% CI: 99.07% to 99.55%).', 0.4263693), ('10.1101/2021.01.20.427541 -- Posted: 2021-01-21 Evolving Insights from SARS-CoV-2 Genome from 200K COVID-19 Patients Desai, S. S., Rane, A., Joshi, A., Dutt, A.', 0.41779238)]"
158,311,A human coronavirus evolves antigenically to escape antibody immunity.,human,a bat coronavirus evolves antigenically to escape antibody immunity.,https://www.biorxiv.org/content/10.1101/2020.12.17.423313v1.full.pdf,Preprint,0.9998028874397278,21492,True,"['biorxiv.org', 'twitter.com', 'nature.com', 'europepmc.org', 'facebook.com']","[('Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection.', 0.7453965), ('Upon infection, an individual’s immune state, possibly impacted by pre-existing antibodies to other coronaviruses (among other mechanisms), may cause harm through immunopathogenesis, and the literature on this topic primarily consists of in vitro experiments.', 0.7361935), ('Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses.', 0.725408), ('Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.', 0.7145282), ('Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection.', 0.7008009)]"
159,312,Danish researchers ' inhalation treatment of Covid-19 passes tests in animals.,animals,danish researchers'inhalation treatment of covid-19 passes tests in patients.,https://nyheder.ku.dk/alle_nyheder/2020/12/danske-forskeres-inhalationsbehandling-af-covid-19-bestaar-test-i-dyr/,Press Release,0.9998026490211488,8898,True,"['ku.dk', 'reddit.com', 'amprogress.org', 'reddit.com', 'linkedin.com']","[('Today, Danish researchers from the University of Copenhagen and Rigshospitalet can together with the Norwegian company SoftOx Solutions announce that their inhalation treatment for COVID-19 is safe to use in animals.', 0.8586594), ('Biopharma Dive: Preclinical done right: The importance of using relevant animal models in gene therapy studies Brink News: How and When Will We Know That a COVID-19 Vaccine Is Safe and Effective?', 0.6068653), ('WLBZ TV: Maine lab genetically modifies mice for COVID-19 research Medical Express: Virologist leads world’s first multi-vaccine animal efficacy studies in the fight against COVID-19 ', 0.5788644), ('Belfast Telegraph: Animal studies could help test for Covid-19 airborne transmission Science: Can boosting interferons, the body’s frontline virus fighters, beat COVID-19?', 0.56019247), ('Futurity: Proof-of-Concept COVID-19 Vaccine Prevents Pneumonia in Mice Texas Public Radio: The COVID-19 Vaccine: Inside America’s Race For An Answer Nature: What the immune response to the coronavirus says about the prospects for a vaccine ', 0.544505)]"
160,313,Cardiorespiratory Fitness and Neuromuscular Performance in Patients Recovered from COVID-19.,recovered,cardiorespiratory fitness and neuromuscular performance in patients died from covid-19.,https://www.medrxiv.org/content/10.1101/2021.01.11.20248930v1,Preprint,0.99980229139328,25538,True,"['medrxiv.org', 'medrxiv.org', 'medrxiv.org', 'medrxiv.org', 'nih.gov']","[('Chronic pain following COVID-19: implications for rehabilitation.', 0.6914343), ('Conclusion Patients recovered from severe COVID-19 present low cardiorespiratory fitness, activate glycolytic fibers at low power outputs, and show low neuromuscular efficiency; while patients recovered from mild COVID-19 do not present these sequels.', 0.6463654), ('COVID-19 infection prevention and control guidance.', 0.6286704), ('It is envisaged that an additional requirement for these procedures will emerge from requests to evaluate individuals recovering from severe COVID-19 infection.7 In this context, measurements obtained from an assessment of cardiorespiratory responses to physiological stress could provide insight regarding the integrity of the pulmonary-vascular interface and characterisation of any impairment or abnormal cardiorespiratory function.', 0.62383574), ('Keywords: cardiopulmonary exercise testing, COVID-19, decision making, diagnostic assessment, endemic phase, preoperative assessment, risk stratification Copyright (C) 2020 British Journal of Anaesthesia.', 0.6117283)]"
163,317,EMA recommends first COVID-19 vaccine for authorisation in the EU.,first,ema recommends no covid-19 vaccine for authorisation in the eu.,https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu,Press Release,0.99979966878891,564,True,"['europa.eu', 'europa.eu', 'europa.eu', 'europa.eu', 'europa.eu']","[('First COVID-19 vaccine authorised for use in the European Union News & events ', 0.8465417), ('Links EMA recommendation: https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu Facts about COVID-19 vaccines on European Vaccination Information Portal: https://vaccination-info.eu/en/covid-19/covid-19-vaccines Announcement on market authorisation by the European Commission: Safe COVID-19 vaccines for Europeans ', 0.81111205), ('EMA’s scientific opinion paves the way for the first marketing authorisation of a COVID-19 vaccine in the EU by the European Commission, with all the safeguards, controls and obligations this entails.', 0.76791), ('The Task Force is helping EU Member States and the European Commission to take quick and coordinated regulatory action on the development, authorisation and safety monitoring of treatments and vaccines intended for the treatment and prevention of COVID-19.', 0.74058104), ('Veklury is the first treatment against COVID-19 in the EU.', 0.7343143)]"
166,330,A false post on social media claims COVID-19 vaccine causes infertility in women.,women,a false post on social media claims covid-19 vaccine causes infertility in dogs.,https://eu.usatoday.com/story/news/factcheck/2020/12/14/fact-check-no-evidence-covid-19-vaccine-causes-infertility-women/3884328001/,Vaccine Research,0.9997960925102234,390,True,"['usatoday.com', 'wkyc.com', 'usatoday.com', 'apnews.com', 'ksat.com']","[('Posts claiming that the COVID-19 vaccine causes infertility in women and sterilization in men appear to be targeting those who are pregnant, looking to conceive, or planning a family in the future.', 0.8057258), ('“It has been incorrectly suggested that COVID-19 vaccines will cause infertility because of a shared amino acid sequence in the spike protein of SARS-CoV-2 and a placental protein,” she said in an email.', 0.7914977), ('""It has been incorrectly suggested that COVID-19 vaccines will cause infertility because of a shared amino acid sequence in the spike protein of SARS-CoV-2 and a placental protein,"" she said in an email to the Associated Press.', 0.7846755), ('It has been incorrectly suggested that COVID-19 vaccines will cause infertility because of a very short amino acid sequence in the spike protein of SARS-CoV-2 virus that is shared with the placental protein, syncytin-1.', 0.7520584), ('KSAT is labeling the claim that the COVID-19 vaccines cause infertility and sterilization as NOT TRUE.', 0.7314144)]"
167,332,Cardiac SARS-CoV-2 infection is associated with distinct transcriptomic changes within the heart.,heart,cardiac sars-cov-2 infection is associated with distinct transcriptomic changes within the lung.,https://www.medrxiv.org/content/10.1101/2020.12.19.20248542v1,Preprint,0.9997957348823548,25538,True,"['medrxiv.org', 'biomedcentral.com', 'medrxiv.org', 'researchgate.net', 'x-mol.com']","[('Indeed, upon SARS-CoV-2 infection, cardiac insufficiency is more likely to occur in these patients where cardiac function is already compromised by myocardial ischemia [4,5,6, 83, 84].', 0.7238312), ('Accordingly, there are several studies reporting a direct effect on heart function of coronaviruses with a pathogenicity similar to that of SARS-CoV-2.', 0.7236147), ('Understanding both direct and indirect damage caused to the heart and the vascular system by SARS-CoV-2 infection is necessary to identify optimal clinical care strategies.', 0.7194195), ('In this autopsy series, cardiac replication of SARS-CoV-2 was associated with early death.', 0.71876097), ('RNA was isolated to examine virus load of SARS- CoV-2 and its replication in the heart.', 0.7046716)]"
172,343,Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques.,reduces,intranasal chadox1 ncov-19/azd1222 vaccination increased shedding of sars-cov-2 d614g in rhesus macaques.,https://www.biorxiv.org/content/10.1101/2021.01.09.426058v1,Preprint,0.9997898936271667,21492,True,"['biorxiv.org', 'nih.gov', 'ox.ac.uk', 'news-medical.net', 'researchgate.net']","[('Intranasal vaccination of rhesus macaques resulted in reduced shedding and a reduction in viral load in bronchoalveolar lavage and lower respiratory tract tissue.', 0.7303857), ('In conclusion, intranasal vaccination reduced shedding in two different SARS-CoV-2 animal models, justifying further investigation as a potential vaccination route for COVID-19 vaccines.', 0.6640191), ('Here we investigate whether intranasally administered ChAdOx1 nCoV-19 reduces shedding, using a SARS-CoV-2 virus with the D614G mutation in the spike protein.', 0.6450641), ('Viral load in swabs obtained from intranasally vaccinated hamsters was significantly decreased compared to controls and no viral RNA or infectious virus was found in lung tissue, both in a direct challenge and a transmission model.', 0.5310737), ('ALS Reproducible Antibody Platform launched Cultural barriers to tackling the superbug crisis ALERRT epidemic research network launched in sub-Saharan Africa Making malaria visible Women in STM Female body shape gene may increase risk of type 2 diabetes The town that breeds resistance to Malaria drugs Can you cure HIV?', 0.4945537)]"
174,347,"As COVID-19 vaccines arrive , Europe looks back at swine flu side effects.",back,"as covid-19 vaccines arrive, europe looks not at swine flu side effects.",https://www.dw.com/en/as-covid-19-vaccines-arrive-europe-looks-back-at-swine-flu-side-effects/a-55813831,General,0.9997882246971128,636,True,"['dw.com', 'fiercepharma.com', 'dw.com', 'ground.news', 'dw.com']","[(""DW: We keep seeing vaccine skeptics referencing the swine flu pandemic in 2009 as the reason they won't be taking a COVID-19 vaccine."", 0.6867391), (""Swine flu death estimates range from 150,000 to more than a half million Why should people not be scared that something similar won't happen with a COVID-19 vaccine?"", 0.67968726), ('COVID-19 vaccines from Moderna , AstraZeneca , Sinopharm and Sinovac are in the “final phase” of review for a possible emergency use listing by the World Health Organization , Reuters reports, citing an internal WHO document.', 0.6531899), ('Meanwhile, the effort to scale up COVID-19 vaccines is affecting other medicines in the pharmaceutical supply chain.', 0.65059507), ('Story Rich countries have cornered global supply of COVID-19 vaccines, suggesting low-risk people in nations like the U.S. will likely be immunized before high-risk people in poorer countries, NPR reports.', 0.64822686)]"
176,353,The US Doesnt Have Enough Hospital Beds For A Bad Coronavirus Outbreak.,doesn,the usset have enough hospital beds for a bad coronavirus outbreak.,https://www.buzzfeednews.com/article/danvergano/coronavirus-hospital-beds-icu,Government Agency,0.9997861981391908,4110,True,"['buzzfeednews.com', 'bloomberg.com', 'cnbc.com', 'vox.com', 'reason.com']","[(""Cuomo warns US won't have enough hospital beds for coronavirus pandemic Published Mon, Mar 16 202011:27 AM EDTUpdated Mon, Mar 16 202012:18 PM EDT Berkeley Lovelace Jr.@BerkeleyJr ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email New York Gov."", 0.70855), ('Earlier in the outbreak, doctors warned that a larger outbreak of the new coronavirus across the U.S. could overwhelm emergency rooms and quickly cause supply shortages of some crucial medical supplies.', 0.69742894), ('A patient was brought into the hospital’s ICU unit; the patient tested negative for flu but did not meet the CDC’s guidelines for coronavirus testing.', 0.69547856), ('Under this example, the market could not be able to recreate enough vaccines if the USA is attacked.', 0.6949555), (""Dillinger March.13.2020 at 12:32 pm >>America Doesn't Have Enough Hospital Beds To Fight the Coronavirus virus impervious to the little wheels."", 0.67317665)]"
177,354,Longitudinal omics in Syrian hamsters integrated with human data unravel complexity of moderate immune responses to SARS-CoV-2.,syrian,longitudinal omics in Chinese hamsters integrated with human data unravel complexity of moderate immune responses to sars-cov-2.,https://www.biorxiv.org/content/10.1101/2020.12.18.423524v1,Preprint,0.9997860789299012,21492,True,"['biorxiv.org', 'researchgate.net', 'biorxiv.org', 'x-mol.com', 'europepmc.org']","[('We performed detailed spatiotemporal analyses of cellular and molecular processes in SARS- CoV-2 infected Syrian hamsters.', 0.70194596), ('Comparison of hamster single-cell sequencing and proteomics with data sets from COVID-19 patients demonstrated inter- species concordance of cellular and molecular host-pathogen interactions.', 0.670009), ('Using the Syrian hamster model of self-limited moderate COVID-19, we defined the specific roles of endothelial and epithelial cells, among other myeloid and non-myeloid lung cell subtypes, for determining the disease course.', 0.6201885), ('In depth vascular and pulmonary compartment analyses (i) supported the hypothesis that monocyte-derived macrophages dominate inflammation, (ii) revealed endothelial inflammation status and T-cell attraction, and (iii) showed that CD4+ and CD8+ cytotoxic T-cell responses precede viral elimination.', 0.52318865), ('Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about bioRxiv.', 0.4134514)]"
181,362,A randomised controlled double blind dose response study in Lagos .,lagos,a randomised controlled double blind dose response study in Taiwan.,https://www.medrxiv.org/content/10.1101/2021.01.05.21249131v1,Preprint,0.9997803568840028,25538,True,"['medrxiv.org', 'covid-nma.com', 'medrxiv.org', 'x-mol.com', 'bvsalud.org']","[('Methods: We conducted a translational proof of concept (PoC) randomized, double blind placebo controlled, dose response, parallel group study of IV efficacy in RT - PCR proven COVID 19 positive patients.', 0.3185029), ('medRxiv - Infectious Diseases Pub Date : 2021-01-06 , DOI: 10.1101/2021.01.05.21249131 Olufemi Emmanuel Babalola; Christopher Olusanjo Bode; Adesuyi Adeyinka Ajayi; Felix M Alakaloko; Iorhen Ephraim Akase; Erere Otrofanowei; Olumuyiwa Babalola Salu; Wasiu Lanre Adeyemo; Adesoji O Ademuyiwa; Sunday A Omilabu Introduction: In vitro studies have shown the efficacy of Ivermectin (IV) to inhibit the SARS - CoV- 2 viral replication, but questions remained as to In- vivo applications.', 0.28958362), ('62 patients were randomized to 3 treatment groups.', 0.2757398), ('Results: The Days to COVID negativity was significantly and dose dependently reduced by IV (p = 0.0066).', 0.23007429), ('Conclusions: 12 mg IV regime may have superior efficacy.', 0.20784882)]"
182,363,"CD177 , a specific marker of neutrophil activation , is a hallmark of COVID-19 severity and death.",death,"cd177, a specific marker of neutrophil activation, is a hallmark of covid-19 severity and development.",https://www.medrxiv.org/content/10.1101/2020.12.12.20246934v1,Preprint,0.999779999256134,25538,True,"['medrxiv.org', 'researchgate.net', 'medrxiv.org', 'bvsalud.org', 'x-mol.com']","[('CD177, a specific marker of neutrophil activation, is a hallmark of COVID-19 severity and ', 0.90732604), ('CD177, a neutrophil activation marker, characterized critically ill patients and marked disease progression and death.', 0.86137927), ('The association of neutrophil activation signature with COVID-19 severity has also been described recently with CD177 gene being one of the most differentially expressed gene in advanced disease 53.', 0.7675732), ('Our finding highlights the major role of neutrophil activation through CD177 over-expression in the critical clinical transition point in the trajectory of COVID-19 patients.', 0.7434063), ('This signature included CD177, a specific neutrophil marker of activation, adhesion to the endothelium, and transmigration.', 0.7174118)]"
187,376,Detection of long SARS-CoV-2 nucleocapsid sequences in peripheral blood monocytes collected soon after hospital admission.,collected,detection of long sars-cov-2 nucleocapsid sequences in peripheral blood monocytes decreased soon after hospital admission.,https://www.biorxiv.org/content/10.1101/2020.12.16.423113v1?rss=1,Preprint,0.99976247549057,21492,True,"['biorxiv.org', 'news-medical.net', 'bvsalud.org', 'google.com', 'twitter.com']","[('Detection of long SARS-CoV-2 nucleocapsid sequences in peripheral blood monocytes collecte ', 0.8303167), ('Detecting SARS-CoV-2 sequences in blood monocytes.', 0.7700238), ('""Detecting SARS-CoV-2 sequences in blood monocytes"".', 0.76464915), ('<https://www.news- medical.net/news/20201221/Detecting-SARS-CoV-2-sequences-in-blood- monocytes.aspx>.', 0.6668195), ('https://www.news-medical.net/news/20201221/Detecting-SARS- CoV-2-sequences-in-blood-monocytes.aspx.', 0.66016006)]"
188,377,German Town Finds a Blueprint for Lowering Covid-19 Deaths.,deaths,german town finds a blueprint for lowering covid-19 transmission.,https://www.wsj.com/articles/german-town-finds-a-blueprint-for-lowering-covid-19-deaths-11609257334,General,0.99976247549057,436,True,"['wsj.com', 'theguardian.com', 'wsj.com', 'ycombinator.com', 'reuters.com']","[('The “Covid-19 case cluster study”, launched on Tuesday morning, will follow 1,000 people who have been chosen because they are representative of the German population as a whole.', 0.614927), ('Now known as Germany’s “Case ', 0.5869121), ('That hunt has helped Germany win crucial time to build its COVID-19 defences.', 0.57190204), ('updated locator The results will be used to create a blueprint for how Germany might deal with the virus over the next few years, said Prof Hendrik Streeck, the head virologist at the University of Bonn.', 0.5653104), ('By then Germany had kicked off a health ministry information campaign and a government strategy to tackle the virus which would hinge on widespread testing.', 0.5582597)]"
190,387,"Researchers Discover New Variant of COVID-19 Virus in Columbus , Ohio.",discover,"researchers no new variant of covid-19 virus in columbus, ohio.",https://wexnermedical.osu.edu/mediaroom/pressreleaselisting/new-sars-cov2-variant,Press Release,0.9997429251670836,5477,True,"['osu.edu', 'osu.edu', '13abc.com', 'wlwt.com', '10tv.com']","[('Scientists at The Ohio State University Wexner Medical Center and College of Medicine have discovered a new strain of COVID-19.', 0.79876626), ('> OSU COVID variant > > Researchers at Ohio State discuss COVID-19 vaccinations and a new variant of > the virus discovered in Columbus.', 0.79831666), ('The Ohio State Wexner Medical Center has been sequencing the genome of SARS- Cov-2 viruses in patients with COVID-19 since March 2020 in order to monitor the evolution of the virus.', 0.70200217), ('The Ohio State Wexner Medical Center has been sequencing the genome of SARS- CoV-2 viruses in patients with COVID-19 since March 2020 in order to monitor the evolution of the virus.', 0.70200217), ('Doctors at Ohio State talked about the COVID-19 vaccine and the new variant of the coronavirus in the briefing below.', 0.7005515)]"
194,393,This is the Stanford vaccine algorithm that left out frontline doctors.,left,this is the stanford vaccine algorithm that carry out frontline doctors.,https://www.technologyreview.com/2020/12/21/1015303/stanford-vaccine-algorithm/,General,0.9997316002845764,9117,True,"['technologyreview.com', 'washingtonpost.com', 'digg.com', 'reddit.com', 'businessinsider.com']","[('In a statement, a representative for Stanford Medical said it took ""complete responsibility"" for issues with the vaccine\'s rollout.', 0.6833279), (""Stanford doctors on Friday protested the system's vaccine rollout plan, as multiple hospitals come under fire for giving too many doses to staff who aren't on the front line, according to reports from San Francisco Chronicle."", 0.6511768), ('Stanford residents protest a photo op to celebrate the arrival of a vaccine.', 0.649629), ('In Stanford\'s case, the hospital\'s chief medical officer, Dr. Niraj Sehgal, apologized to staff this week for ""unintended missteps"" in vaccine rollout, according to a screenshot of the email shared on Twitter.', 0.64296734), ('Jose M. Osorio/Chicago Tribune via AP Doctors protested at Stanford Medical Center Friday, saying the hospital failed to prioritize vaccines for front-line workers and instead gave too many to office staff and others working from home.', 0.6067184)]"
196,395,De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2.,novo,de rational design of potent and resilient hace2 decoys to neutralize sars-cov-2.,https://science.sciencemag.org/content/370/6521/1208,Antivirals,0.9997308850288392,3655,True,"['sciencemag.org', 'nih.gov', 'nih.gov', 'eurekalert.org', 'caltech.edu']","[('Our pipeline allowed the design, validation, and optimization of de novo hACE2 decoys to neutralize SARS-CoV-2.', 0.81434315), ('The high and specific binding affinity of the optimized de novo protein decoys translated into effective and specific in vitro neutralization of SARS-CoV-2 viral infection (Fig.', 0.7449071), ('Our pipeline allowed the design, validation, and optimization of de novo human angiotensin-converting enzyme 2 (hACE2) decoys to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).', 0.71425897), ('We applied our design strategy to engineer, validate, and optimize de novo hACE2 decoys to neutralize SARS-CoV-2 infection (Fig.', 0.65786624), ('F. Li , Cell entry mechanisms of SARS-CoV-2.', 0.6478016)]"
197,396,An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies.,enhancing,an infectivity-independent site on the sars-cov-2 spike protein is targeted by covid-19 patient antibodies.,https://www.biorxiv.org/content/10.1101/2020.12.18.423358v1,Preprint,0.9997292160987854,21492,True,"['biorxiv.org', 'medrxiv.org', 'nature.com', 'asm.org', 'nature.com']","[('Antibody responses to SARS-CoV-2 in patients with COVID-19.', 0.8867341), ('COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses.', 0.8338552), ('Enhancement of SARS-CoV-2 infection of primary B cells by COVID-19 patient plasma.', 0.83020055), ('These findings suggest that the production of antibodies against SARS-CoV-2 infectivity-enhancing site could be considered as a possible exacerbating factors for COVID-19 and that a spike protein lacking such antibody epitopes may be required for safe vaccine development, especially for individuals with pre-existing enhancing antibodies.', 0.8066375), ('Here we reported the observation of in vitro ADE of SARS-CoV-2 entry into FcγRII receptor-bearing cells by plasma and antibodies from patients who recovered from COVID-19.', 0.79688543)]"
202,404,Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients in international trial.,decreased,full-dose blood thinners also need for life support and improved outcomes in hospitalized covid-19 patients in international trial.,https://news.umanitoba.ca/blood-thinners-decreased-need-for-life-support-and-improved-outcomes-in-hospitalized-covid-19-patients/,Press Release,0.9997172951698304,14494,True,"['nih.gov', 'umanitoba.ca', 'prnewswire.com', 'newswise.com', 'precisionvaccinations.com']","[('With large numbers of COVID-19 patients requiring hospitalization, this treatment is expected to reduce the pressure in intensive care units around the world.', 0.7258929), ('Article by Don Ward Hackett Reference: Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients Fact checked by Robert Carlson, MD Relevant Links: CDC Vaccination Schedules Vaccine Price List Vaccines for Children Report Vaccine Side Effects Sponsored Links: Discounts Appointments Clinical Trials Lab Tests ', 0.68052554), ('Most COVID-19 patients hospitalized are non-critical and this study will impact their care and outcomes.', 0.64326847), ('With large numbers of COVID-19 patients requiring hospitalization, these outcomes could also help reduce the overload on intensive care units around the world.', 0.61101985), ('The trials which span four continents have the common goal of assessing the benefit of full doses of blood thinners to treat moderately ill or critically ill adults hospitalized for COVID-19, compared to a lower dose often used to prevent blood clots in hospitalized patients.', 0.60853106)]"
205,410,The COVID-19 pandemic masks the way people perceive faces.,faces,the covid-19 pandemic masks the way people perceive HIV.,https://www.nature.com/articles/s41598-020-78986-9,PPE/Mask Research,0.999701201915741,1167,True,"['nature.com', 'psyarxiv.com', 'researchgate.net', 'nih.gov', 'osf.io']","[('Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic.', 0.75399566), ('The COVID-19 outbreak has led to widespread adoption of face masks as a primary line of protection.', 0.6926803), ('How do surgeons weather the storm of COVID-19 pandemic?', 0.62951815), (""Children's emotion inferences from masked faces: Implications for social interactions during COVID-19."", 0.5556909), ('Coronavirus disease (COVID-19): Measures to reduce COVID-19 in your community.', 0.53586596)]"
208,419,A novel point mutation in the N gene of SARS-CoV-2 may affect the detection of the virus by RT-qPCR.,novel,a third point mutation in the n gene of sars-cov-2 may affect the detection of the virus by rt-qpcr.,https://jcm.asm.org/content/early/2021/01/19/JCM.03278-20,Academic Comment,0.9996619224548341,23947,True,"['asm.org', 'plos.org', 'asm.org', 'nature.com', 'nih.gov']","[('There may be selective mutations in SARS-CoV-2, and it is necessary to avoid certain regions when designing primers and probes.', 0.66264135), ('The large- scale sustained person-to-person transmission of SARS-CoV-2 has led to many mutational events, some of which may affect the sensitivity and specificity of available PCR assays (2).', 0.64560354), ('Finally, RT-qPCR primers are designed to amplify the target regions of the SARS-CoV-2 genome.', 0.6366017), ('A mutation in a reverse primer has been shown to affect the sensitivity of an RT-qPCR assay in use early in the pandemic10 and further mutations could lead to the occurrence of false negative results, particularly if the mutation occurs at the extreme 3′ end of the primers.', 0.6341826), ('Once virus mutation and recombination occur, it is difficult to effectively diagnose viral infection by existing RT-qPCR primers.', 0.6336192)]"
209,420,SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.,induce,sars-cov-2 knocks a durable and antigen specific humoral immunity after asymptomatic to mild covid-19 infection.,https://www.medrxiv.org/content/10.1101/2021.01.03.21249162v1,Preprint,0.9996601343154908,25538,True,"['medrxiv.org', 'news-medical.net', 'medrxiv.org', 'thelancet.com', 'sciencemag.org']","[('Zheng X. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.', 0.8629286), ('Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection.', 0.8565967), ('""Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection"".', 0.84483886), ('Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals.', 0.8188704), ('Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity.', 0.8060353)]"
210,424,"A double-blind , phase 1/2a , randomized controlled trial.",blind,"a double-controlled, phase 1/2a, randomized controlled trial.",https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.20-0472,Academic Report,0.9996330738067628,608,True,"['wiley.com', 'nih.gov', 'clinicaltrials.gov', 'nih.gov', 'sciencemag.org']","[('Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.', 0.5417475), ('Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.', 0.5342177), ('Clinical Trial.', 0.5240185), ('Trials.', 0.49044532), ('You are going to email the following A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1 Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.', 0.47204998)]"
214,429,A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.,human,a novel ace2 isoform is expressed in mouse respiratory epithelia and is upregulated in response to interferons and rna respiratory virus infection.,https://www.nature.com/articles/s41588-020-00759-x,Academic Report,0.9996013045310974,1167,True,"['nature.com', 'biorxiv.org', 'nih.gov', 'ox.ac.uk', 'biorxiv.org']","[('A novel isoform of ACE2 is expressed in human nasal and bronchial respiratory epithelia and is upregulated in response to RNA respiratory virus infection ', 0.9430444), ('Share A novel isoform of ACE2 is expressed in human nasal and bronchial respiratory epithelia and is upregulated in response to RNA respiratory virus infection Cornelia Blume, Claire L Jackson, Cosma Mirella Spalluto, Jelmer Legebeke, Liliya Nazlamova, Franco Conforti, Jeanne-Marie Perotin-Collard, Martin Frank, Max Crispin, Janice Coles, James Thompson, Robert A Ridley, Lareb S N Dean, Matthew Loxham, Adnan Azim, Kamran Tariq, David Johnston, Paul J Skipp, Ratko Djukanovic, Diana Baralle, Chris McCormick, Donna E Davies, Jane S Lucas, Gabrielle Wheway, Vito Mennella bioRxiv 2020.07.31.230870; doi: https://doi.org/10.1101/2020.07.31.230870 Share This Article: Copy Citation Tools A novel isoform of ACE2 is expressed in human nasal and bronchial respiratory epithelia and is upregulated in response to RNA respiratory virus infection Cornelia Blume, Claire L Jackson, Cosma Mirella Spalluto, Jelmer Legebeke, Liliya Nazlamova, Franco Conforti, Jeanne-Marie Perotin-Collard, Martin Frank, Max Crispin, Janice Coles, James Thompson, Robert A Ridley, Lareb S N Dean, Matthew Loxham, Adnan Azim, Kamran Tariq, David Johnston, Paul J Skipp, Ratko Djukanovic, Diana Baralle, Chris McCormick, Donna E Davies, Jane S Lucas, Gabrielle Wheway, Vito Mennella bioRxiv 2020.07.31.230870; doi: https://doi.org/10.1101/2020.07.31.230870 ', 0.79896975), ('Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.', 0.77100015), ('You are going to email the following A novel isoform of ACE2 is expressed in human nasal and bronchial respiratory epithelia and is upregulated in response to RNA respiratory virus infection Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.', 0.764698), ('ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.', 0.7574268)]"
216,432,Mexican Doctor Taken to ICU After Experiencing Serious Reaction to Pfizer Vaccine.,experiencing,mexican doctor taken to icu after no serious reaction to pfizer vaccine.,https://www.ibtimes.sg/mexican-doctor-taken-icu-after-experiencing-serious-reaction-pfizer-vaccine-54608,Vaccine Research,0.9995834231376648,48854,True,"['reddit.com', 'reuters.com', 'wionews.com', 'nbcnews.com', 'ibtimes.sg']","[('A female doctor in Mexico was hospitalized after she received the Pfizer- BioNTech COVID-19 vaccine.', 0.6771308), ('REUTERS/Daniel Becerril MEXICO CITY (Reuters) - Mexican authorities said they are studying the case of a 32-year-old female doctor who was hospitalized after receiving the Pfizer- BioNTech COVID-19 vaccine.', 0.66578317), ('A 32-year-old female doctor in Mexico was hospitalized after receiving the Pfizer-BioNTech COVID-19 vaccine.', 0.6578791), ('Mexican doctor hospitalized after receiving COVID-19 vaccine Wikimedia commons Acute Disseminated Encephalomyelitis ADEM is a rare kind of inflammation that affects the brain and the spinal cord.', 0.6411895), ('The Mexican Health Ministry said in a statement that the initial diagnosis revealed that it was encephalomyelitis, which is an inflammation of the brain and spinal cord.', 0.5754124)]"
219,439,Fast-spreading U.K. virus variant raises alarms.,alarms,fast-spreading u.k. virus variant raises advantage.,https://science.sciencemag.org/content/371/6524/9.full,Academic Comment,0.9995642304420472,3655,True,"['sciencemag.org', 'nih.gov', 'khn.org', 'npr.org', 'nytimes.com']","[('Jason Alden/Bloomberg via Getty Images A new variant of the coronavirus is spreading rapidly in England and raising international alarms.', 0.6326293), ('And when scientists compared how fast this variant, named B.1.1.7, and others were spreading, they made a startling discovery: The virus seemed to have become more adept at transmitting between people.', 0.5713794), ('Variant Continues To Spread Around The World As Coronavirus Pandemic Enters 2021 More than 30 countries have reported cases of the highly transmissible “U.K.', 0.55688936), ('""CREDITS: (IMAGE) COVSURVER ENABLED BY GISAID; (DATA) EMMA HODCROFT/UNIVERSITY OF BERN"" New virus strains are common in outbreaks and often spark alarm, but few are ultimately consequential.', 0.5395087), ('“We found that this lineage seems to be spreading much faster,” says Tulio de Oliveira, a virologist at the University of KwaZulu-Natal whose work alerted U.K. scientists to the mutation.', 0.5334897)]"
220,440,Full-Dose Clot Prophylaxis Halted for Severe COVID-19 in NHLBI Trial.,halted,full-dose clot prophylaxis continued for severe covid-19 in nhlbi trial.,https://www.medpagetoday.com/infectiousdisease/covid19/90351,General,0.9995631575584412,24603,True,"['medpagetoday.com', 'mashupmd.com', 'medpagetoday.com', 'twitter.com', 'medscape.com']","[(""Cite this: COVID-19 Anticoagulation Trials 'Paused' for Futility, Safety - Medscape - Dec 22, 2020."", 0.78013086), ('Informed by the deliberations of the data safety monitoring boards of these trials, all of the trial sites have paused enrollment of the most critically ill hospitalized patients with COVID-19.', 0.6983689), ('All three trials have paused enrollment of critically ill COVID-19 patients requiring intensive care unit support for whom therapeutic doses of anticoagulation drugs did not reduce the need for organ support, the NHLBI statement notes.', 0.692099), ('Severe COVID-19 represents a subset of the inpatient arm of the pragmatic trials, so the less severe hospitalized cases will continue to be randomized to prophylactic versus full therapeutic-dose heparin, a statement from the NHLBI said.', 0.6430304), ('Therapeutic dosing was safe in this moderately ill COVID-19 population, unlike in the critically ill population for which the trials halted the full-dose strategy after seeing signals of harm.', 0.59784615)]"
222,443,Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.,human,neutralization of sars-cov-2 lineage b.1.1.7 pseudovirus by bnt162b2 vaccine-elicited rabbit sera.,https://www.biorxiv.org/content/10.1101/2021.01.18.426984v1,Preprint,0.9995558857917786,21492,True,"['biorxiv.org', 'facultyopinions.com', 'biorxiv.org', 'pfizer.com', 'researchgate.net']","[('Here, we investigated SARS-CoV-2-S pseudoviruses bearing either the Wuhan reference strain or the B.1.1.7 lineage spike protein with sera of 16 participants in a previously reported trial with the mRNA-based COVID-19 vaccine BNT162b2.', 0.74558806), ('Here, we investigated SARS-CoV-2-S pseudoviruses bearing either the Wuhan reference strain or the B.1.1.7 lineage spike protein with sera of 16 participants in a previously reported trial with the mRNA- based COVID-19 vaccine BNT162b2.', 0.74558806), ('The pseudovirus recapitulates SARS-CoV-2 virus binding and cell entry.', 0.6259073), ('Recently, a new SARS-CoV-2 lineage called B.1.1.7 has emerged in the United Kingdom that was reported to spread more efficiently than other strains.', 0.62372625), ('While the pseudovirus system used is a surrogate for authentic SARS-CoV-2, previous studies have shown excellent concordance between pseudotype neutralization and SARS-CoV-2 neutralization assays.i The preserved neutralization of the pseudovirus bearing the U.K. strain spike by BNT162b2- immune sera makes it likely that COVID-19 caused by the U.K. virus variant will also be prevented by immunization with BNT162b2.', 0.62028193)]"
223,449,An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants.,engineered,an natural decoy receptor for sars-cov-2 broadly binds protein s sequence variants.,https://www.biorxiv.org/content/10.1101/2020.10.18.344622v2,Preprint,0.999537467956543,21492,True,"['biorxiv.org', 'nih.gov', 'biorxiv.org', 'illinois.edu', 'nih.gov']","[('Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.', 0.7833233), ('Here, we show that an engineered decoy receptor for SARS-CoV-2 broadly binds with low nanomolar KD to the spikes of SARS-associated betacoronaviruses that use ACE2 for entry, despite high sequence diversity within the ACE2-binding site.', 0.724875), ('Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.', 0.72283596), (', Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.', 0.7127762), ('A. Glasgow et al., Engineered ACE2 receptor traps potently neutralize SARS- CoV-2.', 0.6890005)]"
225,454,A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice.,mice,a single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against sars-cov-2 in humans.,https://pubs.acs.org/doi/10.1021/acscentsci.0c01405,Vaccine Research,0.9995163679122924,2932,True,"['acs.org', 'nih.gov', 'nih.gov', 'news-medical.net', 'researchgate.net']","[('After a single dose, mice immunized with SΔC-Fer exhibited a significantly higher neutralizing antibody response than all nonferritin groups as determined using a spike-pseudotyped lentiviral assay.', 0.82811123), ('Taken together, these results provide insights into development of SARS-CoV-2 subunit vaccines and demonstrate that spike- functionalized ferritin nanoparticles elicit an enhanced antibody response compared to the spike trimers or RBD alone.', 0.8145529), ('To assess the immune response in vivo , we immunized mice and characterized the antibody responses to the spike ferritin particles versus S-GCN4, SΔC-GCN4, and RBD.', 0.8135504), ('Taken together, these results provide insights into the development of SARS-CoV-2 subunit vaccines and demonstrate that spike-functionalized ferritin nanoparticles elicit an enhanced antibody response compared to the spike trimers or RBD alone.', 0.80832636), ('Analysis of antisera from immunized mice revealed that the only groups with notable neutralizing activity after a single dose of antigen were those immunized with S-Fer or SΔC-Fer (Figure 4C), underscoring that multivalent presentation greatly enhances the neutralizing antibody response in a single- dose regimen of an adjuvanted SARS-CoV-2 subunit vaccine.', 0.8080404)]"
226,456,Iran says coronavirus has spread to several cities.,cities,iran says coronavirus has spread to several species.,https://edition.cnn.com/asia/live-news/coronavirus-outbreak-02-21-20-intl-hnk/h_6adad88d14237bad8f0f2e821121aa60,Government Agency,0.9995052814483644,64,True,"['reuters.com', 'usnews.com', 'cnn.com', 'cnn.com', 'cnbc.com']","[('Related Coverage Coronavirus has spread to several Iranian cities: health ministry official The new cases comprised seven people diagnosed in Qom, four in the capital Tehran and two in Gilan province, Health Ministry spokesman Kianush Jahanpur said in a tweet.', 0.77693653), ('""Based on existing reports, the spread of the coronavirus started in Qom and with attention to people\'s travels has now reached several cities in the country, including Tehran, Babol, Arak, Isfahan, Rasht, and other cities.', 0.7439204), ('> “The spread of the coronavirus started in Qom and has reached other cities > in the country like Tehran, Babol, Arak, Isfahan, Rasht and other cities due > to people traveling.', 0.6699933), ('“Based on existing reports, the spread of coronavirus started in Qom and with attention to people’s travels has now reached several cities in the country including Tehran, Babol, Arak, Isfahan, Rasht and other cities,” health ministry official Minou Mohrez said, according to the official IRNA news agency.', 0.6696086), ('Earlier in the day, Iran confirmed 13 new coronavirus cases.', 0.59277093)]"
229,461,Rogue antibodies could be driving severe COVID-19.,could,rogue antibodies cannot be driving severe covid-19.,https://www.nature.com/articles/d41586-021-00149-1,Academic Comment,0.9994458556175232,1167,True,"['nature.com', 'nih.gov', 'nih.gov', 'rockefeller.edu', 'theguardian.com']","[('The Covid-19 patients had more antibodies that had turned on them than people with lupus, an autoimmune disease caused by similar wayward antibodies.', 0.7568793), ('[2] Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.', 0.7549244), ('Those antibodies, which blocked the interferons’ antiviral activity, weren’t found in people with more mild cases of COVID-19.', 0.72251683), ('Rather than one type of autoantibody being to blame, the scientists believe that Covid-19 is worsened when many different wayward antibodies arise in the same patient.', 0.6987559), ('It’s unclear whether COVID-19 infection caused the body to start making these autoantibodies or whether infected people had them already.', 0.68213934)]"
233,470,European Commission authorises first safe and effective vaccine against COVID-19.,first,european commission authorises another safe and effective vaccine against covid-19.,https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2466,Press Release,0.9993888139724731,564,True,"['europa.eu', 'youtube.com', 'europa.eu', 'europa.eu', 'uemo.eu']","[('Previous post UEMO featured in EMA public meeting on COVID-19 vaccines ', 0.60121274), ('This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed by the Member States.', 0.5842018), ('This procedure, specifically designed for emergency situations, ensures as swift an assessment as possible while ensuring that all requirements in terms of safety, effectiveness and quality of the vaccine are fully and thoroughly evaluated.', 0.48434338), ('BioNTech and Pfizer made a formal application for a conditional marketing authorisation on 1 December.', 0.37292272), (': Digital Object Identifier : International Standard Serial Number : Medicines and Healthcare products Regulatory Agency : National Institute for Biological Standards and Control : Clinical Practice Research Datalink : Commission on Human Medicines [Today at 9:21 AM]: Saturday, January 23, 2021 at 9:21 AM [ Yesterday at 9:15 AM]: Friday, January 22, 2021 at 9:15 AM [January 21 at 10:54 AM]: Thursday, January 21, 2021 at 10:54 AM [ Genome Res.', 0.3192013)]"
234,471,"All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Ages 25-44 Years , March-July 2020.",mortality,"all-cause excess mortality and covid-19–related mortality among us adults ages 25-44 years, march-july 2016.",https://jamanetwork.com/journals/jama/fullarticle/2774445,Academic Report,0.9993873834609984,9963,True,"['jamanetwork.com', 'washington.edu', 'medrxiv.org', 'cdc.gov', 'jamanetwork.com']","[('Excess deaths from COVID-19 and other causes, March-July 2020.', 0.72023845), ('Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity -- United States, January 26-October 3, 2020.', 0.7084087), ('Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020.', 0.6598416), ('These disproportionate increases among certain racial and ethnic groups are consistent with noted disparities in COVID-19 mortality.', 0.61368966), ('Weekly numbers of deaths from all causes and from all causes excluding COVID-19 relative to the average expected number and the upper bound of the 95% prediction interval (A), and the weekly and total numbers of deaths from all causes and from all causes excluding COVID-19 above the average expected number and the upper bound of the 95% prediction interval (B) -- National Vital Statistics System, United States, January-September 2020 Abbreviation: COVID-19 = coronavirus disease 2019.', 0.5969204)]"
236,479,Mutant coronavirus in the United Kingdom sets off alarms but its importance remains unclear.,unclear,mutant coronavirus in the united kingdom sets off alarms but its importance remains clear.,https://www.sciencemag.org/news/2020/12/mutant-coronavirus-united-kingdom-sets-alarms-its-importance-remains-unclear,Academic Comment,0.999338686466217,3655,True,"['sciencemag.org', 'mashupmd.com', 'sciencemag.org', 'europa.eu', 'missoulacurrent.com']","[('Since the novel coronavirus was first discovered in China, it has undergone many mutations but WHO experts say such changes are to be expected and that they have not been so extreme as to make vaccines being developed against it ineffective.', 0.5920569), ('The threat caused by the coronavirus variant remains unclear, though if it spreads more easily that poses a clear danger.', 0.5891386), ('(AP Photo/Kirsty Wigglesworth via CN) (CN) — A potentially dangerous mutation of the novel coronavirus found to be spreading rapidly in the United Kingdom is causing alarm across Europe and prompting countries to close off travel with Britain.', 0.52824605), ('Drosten notes that the new mutant also carries a deletion in another viral gene, ORF8, that previous studies suggest might reduce the virus’ ability to spread.', 0.47432157), ('On Saturday, the U.K. imposed strict lockdown measures to stop the spread of a new variant of the virus that British Prime Minister Boris Johnson said is much more transmissible, though he said there was no evidence it was more lethal or more resistant to vaccines.', 0.44121864)]"
237,485,The SARS-CoV-2 spike protein disrupts the cooperative function of human cardiac pericytes.,disrupt,the sars-cov-2 spike protein closelys the cooperative function of human cardiac pericytes.,https://www.biorxiv.org/content/10.1101/2020.12.21.423721v1,Preprint,0.9992788434028624,21492,True,"['biorxiv.org', 'bris.ac.uk', 'biorxiv.org', 'twitter.com', 'medrxiv.org']","[('Yet, it is not clear if SARS-CoV-2 triggers adverse responses in cardiac vascular mural cells.', 0.6334485), ('The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses primarily the capsid spike (S) protein to engage with its receptors and infect host cells.', 0.5554153), ('Evidence before this study The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses primarily the capsid spike (S) protein to engage with its receptors and infect host cells.', 0.52169806), ('To date, it is still not known if the S protein alone, without the other viral elements, is able to trigger vascular cell signalling and provoke cell dysfunction.', 0.48680156), ('To date, it is still not known if the S protein alone, without the other viral elements, is able to trigger vascular cell signalling and provoke cell dysfunction.Methods We investigated the effects of the recombinant, stabilised S protein on primary human cardiac pericytes (PCs) signalling and function.', 0.47792095)]"
238,488,Ohio researchers say they 've identified two new Covid strains likely originating in the U.S .,two,ohio researchers say they've identified all new covid strains likely originating in the u.s.,https://www.cnbc.com/2021/01/13/ohio-researchers-say-theyve-identified-two-new-covid-strains-likely-originating-in-the-us.html,General,0.9992536902427672,239,True,"['cnbc.com', 'khn.org', 'nbcnewyork.com', 'theohiocouncil.org', 'gizmodo.com']","[('Fox News: 2 New Coronavirus Variants That Likely Originated In US Identified In Ohio: Researchers Ohio researchers on Wednesday announced that they’ve identified two coronavirus variants that likely originated in the United States.', 0.64041424), ('But the researchers say they’ve come across two variants that could be trouble.', 0.5788988), (""Researchers in Ohio said Wednesday that they've discovered two new variants of the coronavirus that likely originated in the U.S. — one of which quickly became the dominant strain in Columbus, Ohio, over a three-week period in late December and early January."", 0.5322931), ('The variants were found by researchers at The Ohio State University.', 0.5208841), (""Published Wed, Jan 13 202110:07 AM ESTUpdated Wed, Jan 13 20214:43 PM EST Will ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Key Points Ohio researchers said Wednesday that they've discovered two new variants of the coronavirus, one of which has become the dominant strain in Columbus, Ohio."", 0.49274167)]"
240,490,"As a doctor , Ive studied the data swirling around this perplexing Covid virus .",doctor,"as a state, ive studied the data swirling around this perplexing covid virus.",https://www.rt.com/op-ed/511467-covid-confusion-deaths-lockdown/,General,0.9992293119430542,306,True,"['rt.com', 'reddit.com', 'twitter.com', 'reddit.com', 'twitter.com']","[('Also on rt.com As a doctor, people ask me if it’s safe to take a new Covid vaccine.', 0.5816542), (""Also on rt.com Fewer than 400 healthy people under 60 have died of Covid in England, so it’s not wrong to question our response to the pandemic What I have been waiting to see is the virus' impact on the one outcome that you cannot alter, or fudge."", 0.53531694), (""His blog can be read here and his book, 'Doctoring Data - How to Sort Out Medical Advice from Medical Nonsense,' is available here."", 0.47287184), ('Did someone die with Covid-19, of Covid-19 - or did it have nothing to do with the virus?', 0.430852), ('I hacked down to establish the way that Covid-19 deaths are recorded.', 0.42982176)]"
242,497,IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2.,two,ifn-α2a therapy in 5 patients with inborn errors of tlr3 and irf3 infected with sars-cov-2.,https://link.springer.com/article/10.1007/s10875-020-00933-0,Academic Comment,0.9991563558578492,520,True,"['nih.gov', 'springer.com', 'nih.gov', 'springer.com', 'elsevierpure.com']","[('The rationale for proposing IFN-α2a treatment to these two patients was based on (i) the impairment of type I IFN production by both AD TLR3 and IRF3 deficiencies [2,3,4,5]; (ii) the development of severe COVID-19, sometimes with a fatal outcome, in some patients with IEIs affecting type I IFN production; (iii) the anosmia/ageusia in both patients, whose IEI predispose to HSE, and the tropism of SARS-Cov2 for the central nervous system, which together stressed a risk of neurological manifestations of COVID-19; (iv) the high susceptibility of TLR3-deficient fibroblasts to SARS-Cov2 in vitro, a phenotype rescued by exogenous type I IFN; (v) the diagnosis of these two patients with COVID-19 at a very early stage of clinical manifestations, placing both patients in the so-called first phase of COVID-19; and (vi) the known safety profile of a single dose of Peg-IFN-α2a.', 0.7393477), ('Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.', 0.5707394), ('Our findings cannot be considered a formal demonstration of the efficacy of IFN-α2a therapy for COVID-19, but both patients reported a rapid resolution of the symptoms and signs present at admission following the administration of Peg-IFN-α2a.', 0.5663108), ('Real-time PCR (RT-PCR) on a nasal swab collected on admission (day 2 of symptoms) confirmed a high viral load of SARS-Cov2 (Ct: 23).', 0.5619381), ('We report here the safety of a single subcutaneous injection of Peg-IFN-α2a in two patients with IEIs affecting the production of type I IFNs associated with a predisposition to severe COVID-19.', 0.5552666)]"
243,502,"Remdesivir induced viral RNA and subgenomic RNA suppression , and evolution of viral variants in SARS-CoV-2 infected patients.",patients,"remdesivir induced viral rna and subgenomic rna suppression, and evolution of viral variants in sars-cov-2 infected plants.",https://www.medrxiv.org/content/10.1101/2020.11.18.20230599v1,Preprint,0.9991362690925598,25538,True,"['medrxiv.org', 'cogconsortium.uk', 'researchgate.net', 'bvsalud.org', 'google.com']","[('Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral varian ', 0.8567371), ('Summary SentenceDeep sequencing of longitudinal samples from SARS-CoV-2 infected paediatric patients identifies evidence of remdesivir-associated inhibition of viral replication in vivo and uncovers evidence of within host evolution of distinct viral genotypes.', 0.814355), ('Sequential viral loads and deep sequencing of SARS-CoV-2 recovered from the upper respiratory tract of hospitalised children revealed that remdesivir treatment suppressed viral RNA levels in one patient but not in a second infected with an identical strain.', 0.6809279), ('Reduced levels of subgenomic (sg) RNA during treatment of the second patient, suggest an additional effect of remdesivir on viral replication that is independent of viral RNA levels.', 0.6777168), ('Main content 1 Search 2 Footer 3 +A A -A High contrast COVID-19 Global literature on coronavirus disease العربية 中文 (中国) english français Русский español português Advanced Search Title, abstract, subject Title Author Abstract Search 1.', 0.5581894)]"
244,503,N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.,vulnerability,n-terminal domain antigenic mapping reveals a site of conservation for sars-cov-2.,https://www.biorxiv.org/content/10.1101/2021.01.14.426475v1,Preprint,0.9991217255592346,21492,True,"['biorxiv.org', 'nih.gov', 'vir.bio', 'medrxiv.org', 'sciencemag.org']","[('We define an antigenic map of the SARS-CoV-2 NTD and identify a supersite recognized by all known NTD-specific neutralizing mAbs.', 0.74007475), ('D. Veesler , Structure, function, and antigenicity of the SARS-CoV-2 Spike glycoprotein.', 0.7087393), (', Potent human neutralizing antibodies elicited by SARS-CoV-2 infection.', 0.6876355), ('L. Zhang , Human neutralizing antibodies elicited by SARS-CoV-2 infection.', 0.6706906), ('These results indicate that antibody responses elicited by natural SARS-CoV-2 infection were diverse in epitope recognition of S proteins.', 0.6694484)]"
245,508,Identifying silent COVID-19 infections among children is critical for controlling the pandemic.,children,identifying silent covid-19 infections among adults is critical for controlling the pandemic.,https://www.medrxiv.org/content/10.1101/2021.01.06.21249349v1,Preprint,0.9990299940109252,25538,True,"['medrxiv.org', 'nih.gov', 'medrxiv.org', 'yale.edu', 'oup.com']","[('Conclusions and relevance: In the absence of vaccine availability for children, a targeted approach to rapid identification of silent COVID-19 infections in this age group can significantly mitigate disease burden.', 0.7497673), ('Conclusions and Relevance In the absence of vaccine availability for children, a targeted approach to rapid identification of silent COVID-19 infections in this age group can significantly mitigate disease burden.', 0.7353116), ('Key points: Question: What is the impact of a targeted strategy for identification of silent COVID-19 infections among children in the absence of their vaccination?', 0.72205293), ('Question What is the impact of a targeted strategy for identification of silent COVID-19 infections among children in the absence of their vaccination?', 0.7107487), ('The implications of silent transmission for the control of COVID-19 outbreaks.Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP.', 0.6873274)]"
249,517,A more contagious coronavirus strain has been found in 8 states and 33 countries .,more,a single contagious coronavirus strain has been found in 8 states and 33 countries.,https://www.usatoday.com/story/news/health/2021/01/02/new-covid-strain-b-117-explained/4112125001/,General,0.998881995677948,390,True,"['usatoday.com', 'yahoo.com', 'nytimes.com', 'nymag.com', 'deadline.com']","[('The nation now has more than 20 million confirmed coronavirus cases.', 0.5759915), ('The strain has been detected in at least 33 countries, including Australia, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Iceland, India, Ireland, Israel, Italy, Japan, Jordan, Lebanon, Malta, The Netherlands, Norway, Pakistan, Portugal, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, Turkey, the United Arab Emirates, the United Kingdom and the United States.', 0.5040444), ('At least eight U.S. states and 33 countries have identified the new variant, known as B.1.1.7.', 0.4273337), ('Less than a week later, the county reported 32 cases of the new strain have been detected.', 0.39572686), ('The virus would ""likely need to accumulate multiple mutations in the spike protein to evade immunity induced by vaccines or by natural infection,"" according to the CDC.', 0.37201434)]"
250,518,Moderna Provides COVID-19 Vaccine Supply Update.,modern,CDCa provides covid-19 vaccine supply update.,https://investors.modernatx.com/news-releases/news-release-details/moderna-provides-covid-19-vaccine-supply-update,Press Release,0.9988794922828674,35362,True,"['modernatx.com', 'yahoo.com', 'modernatx.com', 'chronicle-tribune.com', 'nasdaq.com']","[('Story continues About the Moderna COVID-19 Vaccine The Moderna COVID-19 Vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center.', 0.7106434), ('About the Moderna COVID-19 Vaccine The Moderna COVID-19 Vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center.', 0.70910954), ('On December 18, 2020, the FDA authorized the emergency use of the Moderna COVID-19 Vaccine in individuals 18 years of age or older.', 0.6881626), ('Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding: the Company’s development of a vaccine against the novel coronavirus, and the timeline and scale for manufacturing and distribution of the Moderna COVID-19 Vaccine.', 0.68790317), ('The vaccine received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) on December 18, 2020 and Moderna began supplying to the government shortly thereafter.', 0.66008145)]"
251,524,SARS-CoV-2-Specific Antibody Profiles Distinguish Patients with Moderate from Severe COVID-19.,profiles,sars-cov-2-specific antibody cannot distinguish patients with moderate from severe covid-19.,https://www.medrxiv.org/content/10.1101/2020.12.18.20248461v1,Preprint,0.9988365769386292,25538,True,"['medrxiv.org', 'news-medical.net', 'medrxiv.org', 'x-mol.com', 'researchgate.net']","[('To explore the potential relationship between virus-specific humoral responses and COVID-19 immunopathology, we measured serum antibody classes and subclasses to the receptor-binding domain of the SARS-CoV-2 spike protein and the nucleoprotein in a cohort of hospitalized COVID-19 patients with moderate to severe disease.', 0.7865264), ('They found higher amounts of receptor-binding domain (RBD) antibody classes and subclasses in the COVID-19 patients than pre-pandemic control samples.', 0.71394306), ('""SARS-CoV-2 antibody levels and types differ by disease severity, study finds"".', 0.66297096), ('SARS-CoV-2 antibody levels and types differ by disease severity, study finds.', 0.66221875), ('The observations of IgA2 in some COVID-19 patients suggest a gut immune response.', 0.6317708)]"
252,527,Early immune pathology and persistent dysregulation characterise severe COVID-19.,early,Severe immune pathology and persistent dysregulation characterise severe covid-19.,https://www.medrxiv.org/content/10.1101/2021.01.11.20248765v1,Preprint,0.9987528324127196,25538,True,"['medrxiv.org', 'biomedcentral.com', 'ssrn.com', 'europepmc.org', 'nih.gov']","[('Keywords: COVID-19, Immunopathogenesis, SARS-CoV-2, Immune dysregulation ', 0.8203429), ('Dysregulation in the immune system can lead to an unappropriated local and systemic immune responses and subsequently the rapid spread of the virus, leading to severe COVID-19 disease.', 0.7992418), ('showed that COVID-19 patients display a severe immunosuppressive phenotype.', 0.783938), ('Complex immune dysregulation in COVID-19 patients with severe respiratory failure.', 0.7800518), ('An inflammatory cytokine signature predicts COVID-19 severity and survival.', 0.7749051)]"
255,538,New coronavirus variant is identified in UK.,new,No coronavirus variant is identified in uk.,https://www.bmj.com/content/371/bmj.m4857,Academic Comment,0.998344659805298,4780,True,"['cdc.gov', 'bmj.com', 'bbc.com', 'nih.gov', 'bbc.com']","[('The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world.', 0.58078706), (""England's Chief Medical Officer Prof Chris Whitty said current coronavirus swab tests would detect the new variant that has been found predominantly in Kent and neighbouring areas in recent weeks."", 0.5608143), ('It is thought the variant either emerged in a patient in the UK or has been imported from a country with a lower ability to monitor coronavirus mutations.', 0.52425003), ('A number of variants have already been detected in the UK.', 0.5239368), ('Matt Hancock said the new variant of coronavirus ""may be associated"" with the faster spread in the south-east of England.', 0.49221373)]"
258,549,'Everything Will Be on the Table '.,table,'everything will be on the top '.,https://www.msn.com/en-us/health/medical/dr-fauci-on-mandatory-covid-vaccines-everything-will-be-on-the-table/ar-BB1coEbK?ocid=uxbndlbing,General,0.9980934262275696,57,True,"['newsweek.com', 'msn.com', 'nypost.com', 'cnn.com', 'theguardian.com']","[('""But if we win the majority, everything is on the table.""', 0.746546), ('So we discuss everything.', 0.48866105), ('Anything is possible, of course.""', 0.39779684), ('But these are all things that will be discussed [under the Biden administration].""', 0.37112164), ('See Odds ', 0.360956)]"
262,564,Ferritin nanoparticle based SARS-CoV-2 RBD vaccine induces persistent antibody response and long-term memory in mice.,mice,ferritin nanoparticle based sars-cov-2 rbd vaccine induces persistent antibody response and long-term memory in humans.,https://www.biorxiv.org/content/10.1101/2020.12.22.423894v1,Preprint,0.9972203969955444,21492,True,"['biorxiv.org', 'x-mol.com', 'biorxiv.org', 'x-mol.com', 'europepmc.org']","[('Here, we report that a ferritin nanoparticle based SARS-CoV-2 RBD vaccine induced in mice an efficient antibody response which lasts for at least 7 months post immunization.', 0.7994542), ('Thus, we believe our current study provide the first information about the long-term antibody persistence and memory response of a COVID-19 vaccine.', 0.63627964), ('Significantly higher number of memory B cells were maintained and a significantly higher level of recall response was induced upon antigen challenge.', 0.4961427), ('However, the antibody persistence over 3 months post immunization and the long-term memory have been rarely reported.', 0.48118895), ('This information would be also timely useful for the development and evaluation of other vaccines.', 0.44018775)]"
265,570,Fibrinolysis influences SARS-CoV-2 infection in ciliated cells.,infection,fibrinolysis influences sars-cov-2 production in ciliated cells.,https://www.biorxiv.org/content/10.1101/2021.01.07.425801v1,Preprint,0.9971281886100768,21492,True,"['biorxiv.org', 'nih.gov', 'biorxiv.org', 'europepmc.org', 'twitter.com']","[('Accordingly, SARS-CoV-2 may share and strengthen the ENaC fibrinolytic proteases network in ACE2 positive airway and alveolar epithelial cells, which may expedite virus infusion into the susceptible cells and bring about ENaC associated edematous respiratory condition.', 0.7043973), ('SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.', 0.67838705), ('Plasmin, and other host proteases, may cleave the furin site of SARS-CoV-2 S protein and γ subunits of epithelial sodium channels (γ ENaC), resulting in an increment in virus infectivity and channel activity.', 0.6230166), ('Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.', 0.55096155), ('As for the importance of ENaC in the regulation of airway surface and alveolar fluid homeostasis, whether SARS-CoV-2 will share and strengthen the cleavage network with ENaC proteins at the single-cell level is urgently worthy of consideration.', 0.52235377)]"
267,572,"China Reports Smallest Number Of New COVID-19 Cases Since January , But That Doesnt Mean Virus Is Peaking.",doesn,"china reports smallest number of new covid-19 cases since january, but that ht mean virus is peaking.",https://khn.org/morning-breakout/china-reports-smallest-number-of-new-covid-19-cases-since-january-but-that-doesnt-mean-virus-is-peaking/,News Article,0.9970086216926576,39003,True,"['khn.org', 'cnbc.com', 'bbc.com', 'npr.org', 'theguardian.com']","[('Chinese officials said that part of those 19,000 new cases were older cases that had been clinically diagnosed, but not confirmed in a lab.', 0.61626625), ('ET ""Yesterday, the number of new cases reported outside China exceeded the number of new cases in China for the first time,"" the head of the World Health Organization said Wednesday in an update on the coronavirus disease COVID-19.', 0.56800926), ('Only one in 19 infected people in Wuhan was being tested and confirmed, according to an estimate by Imperial College London as of Jan. 31.', 0.5534082), (""He has also recently noted that the virus's fatality rate outside of Hubei province is less than 1%."", 0.52045655), ('Photograph: Noel Celis/AFP/Getty China’s Hubei province has reported its lowest number of new coronavirus cases since January, giving officials hope that the outbreak may be approaching its peak even as experts remained wary about its spread outside of China.', 0.5036006)]"
275,591,COVID-19 vasculitis and novel vasculitis mimics.,mimic,covid-19 vasculitis and novel vasculitis adverses.,https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30420-3/fulltext,Academic Report,0.9948766827583312,8353,True,"['thelancet.com', 'researchgate.net', 'thelancet.com', 'reddit.com', 'facebook.com']","[('What is the evidence that neurological disease related to COVID-19 in humans represents a vasculitis mimic?', 0.7672465), ('We describe the basis for the different patterns of genuine vasculitis associated with COVID-19, including isolated cutaneous vasculitis, Kawasaki disease and Kawasaki-like disease, and COVID-19 vasculitis mimics.', 0.7520889), ('Concurrent chilblains and retinal vasculitis in a child with COVID-19.', 0.7346256), ('D) The vasculitis mimics seen in severe COVID-19 pneumonia, associated with cardiac disease, are likely to be linked to multifaceted mechanisms consequent to severe pulmonary territory immunothrombosis, hypoxaemia, pulmonary hypertension, pulmonary venular territory embolism, arterial thromboembolism, and systemic venous thromboembolism.', 0.72040105), ('2020; 34: e764-e766 Crossref PubMed Scopus (4) Google Scholar Figure 1 Patterns of disease leading to vasculitis and vasculitis mimics Show full caption Two distinct mechanisms underscore the cutaneous disease seen in COVID-19.', 0.7041185)]"
276,593,Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2.,inhibit,repurposing of miglustat to investigate the coronavirus severe acquired respiratory syndrome sars-cov-2.,https://www.biorxiv.org/content/10.1101/2020.05.18.101691v1,Preprint,0.9944034814834596,21492,True,"['biorxiv.org', 'researchgate.net', 'genscript.com', 'medrxiv.org', 'bvsalud.org']","[('Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome S ', 0.9380436), ('The mechanism resides in the inhibitory activity towards α-glucosidases that are involved in early stages of glycoprotein N-linked oligosaccharide processing in the endoplasmic reticulum, leading to a marked decrease of the viral Spike protein.', 0.46697038), ('The mechanism resides in the inhibitory activity towards -glucosidases that are involved in early stages of glycoprotein N-linked oligosaccharide processing in the endoplasmic reticulum, leading to a marked decrease of the viral Spike protein.', 0.45646176), ('The activity of Miglustat is here demonstrated for SARS-CoV-2 at concentrations achievable in the plasma by current clinical regimens without cytotoxicity.', 0.45460093), ('The iminosugar Miglustat is a well-characterized drug for the treatment of rare genetic lysosome storage diseases such as Gaucher and Niemann-Pick type C, and has also been described to be active against a variety of enveloped viruses.', 0.44522765)]"
277,594,Immunological characteristics govern the transition of COVID-19 to endemicity.,endemic,immunological characteristics govern the transition of covid-19 to economicity.,https://science.sciencemag.org/content/early/2021/01/11/science.abe6522.full,Academic Report,0.994281768798828,3655,True,"['sciencemag.org', 'nih.gov', 'medrxiv.org', 'nih.gov', 'researchgate.net']","[('You are going to email the following Immunological characteristics govern the changing severity of COVID-19 during the transition to endemicity Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.708753), ('G. M. Leung , Temporal dynamics in viral shedding and transmissibility of COVID-19.', 0.64398825), ('H. Yu , Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China.', 0.6426182), ('Share Immunological characteristics govern the changing severity of COVID-19 during the transition to endemicity Jennie S Lavine, Ottar N Bjornstad, Rustom Antia medRxiv 2020.09.03.20187856; doi: https://doi.org/10.1101/2020.09.03.20187856 Share This Article: Copy Citation Tools Immunological characteristics govern the changing severity of COVID-19 during the transition to endemicity Jennie S Lavine, Ottar N Bjornstad, Rustom Antia medRxiv 2020.09.03.20187856; doi: https://doi.org/10.1101/2020.09.03.20187856 ', 0.62356067), ('The key insights come from how our model explicitly incorporates different components of immunological protection with respect to susceptibility, pathology and infectivity (IES, IEP and IEI) and their different rates of waning.', 0.5932572)]"
278,596,The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19.,with,the neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients without covid-19.,https://www.cell.com/cell-metabolism/fulltext/S1550-4131(21)00002-4,Clinical,0.9941179752349854,13894,True,"['researchsquare.com', 'cell.com', 'researchgate.net', 'nih.gov', 'nih.gov']","[('Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.', 0.8119844), ('Keywords: COVID-19; corticosteroids; inflammatory status; mortality; neutrophil-to-lymphocyte ratio.', 0.7887518), ('This finding may assist clinical evaluation and future randomized controlled trials to establish proper guidelines for corticosteroid therapy in COVID-19 patients.', 0.78334117), ('Therefore, our study has uncovered NLR as a clinical indicator to stratify COVID-19 patients in their response to corticosteroid therapy.', 0.7212263), ('Can COVID-19 Mortality be Predicted in the Emergency Room?', 0.67625093)]"
279,597,Rapid evaluation confirms lateral flow devices effective in detecting new COVID-19 variant.,detecting,rapid evaluation confirms lateral flow devices effective in generating new covid-19 variant.,https://www.gov.uk/government/news/rapid-evaluation-confirms-lateral-flow-devices-effective-in-detecting-new-covid-19-variant,Press Release,0.9939648509025574,681,True,"['www.gov.uk', 'onmedica.com', 'wired-gov.net', 'companynewshq.com', 'reddit.com']","[('LFDs are one of the new tools being used to help detect COVID-19 and results can be delivered rapidly in under 30 minutes.', 0.7454061), ('This is good news as it means they can continue to be used to find > people who have COVID-19 without symptoms who might be unknowingly passing > it on.', 0.5977135), ('Testing for coronavirus (COVID-19) Press release ', 0.5356786), ('Dr Susan Hopkins, Senior Medical Advisor to PHE and NHS Test and Trace, said: > This rapid evaluation confirms that lateral flow devices can detect the new > variant.', 0.5084272), ('Each device successfully detected samples containing the new variant.', 0.507607)]"
280,599,Russia claims it produces drug to treat COVID-19.,drug,russia claims it produces strategies to treat covid-19.,https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/russia-claims-it-produces-drug-to-treat-covid-19-/1783292,General,0.9938283562660216,1709,True,"['aa.com.tr', 'cnbc.com', 'reuters.com', 'thedailybeast.com', 'sciencemag.org']","[('""Avifavir is Russia\'s first Covid-19 drug and has shown high efficacy in treating patients with coronavirus during clinical trials.', 0.62203634), (""VIDEO3:1803:18 Russia to start using Avifavir as a Covid-19 treatment from June Squawk Box Europe Russia has approved an anti-influenza drug, Aviifavir, to treat Covid-19 and will start delivering it to hospitals this month, according to Russia's sovereign wealth fund."", 0.60873556), ('Thus, Avifavir has become the first Favipiravir-based drug in the world approved for the treatment of Covid-19,"" they said in the statement.', 0.56932503), ('Preliminary trials appeared to show that it could shorten recovery times for patients with Covid-19.', 0.5558641), (""Russia's Ministry of Health on Saturday temporarily approved the use of the drug as a coronavirus treatment."", 0.5365928)]"
281,603,"China 's Sinovac vaccine 78 % effective , says Brazil.",brazil,"china's sinovac vaccine 78 % effective, says 2005.",https://www.dw.com/en/coronavirus-digest-chinas-sinovac-vaccine-78-effective-says-brazil/a-56153810,Vaccine Research,0.9932156205177308,636,True,"['dw.com', 'reuters.com', 'cnbc.com', 'bloomberg.com', 'apnews.com']","[('The Sinovac vaccine is one of at least five Chinese shots undergoing late- stage trials The coronavirus vaccine developed by Chinese company Sinovac Biotech was found to be 78% effective in late-stage trials in Brazil , Brazilian media reported Thursday.', 0.734571), ('(AP Photo/Eraldo Peres) SAO PAULO (AP) — A vaccine candidate made by China’s Sinovac is 78% effective in protecting against the coronavirus, according to results of a study announced Thursday by Brazilian state health officials seeking federal approval of the shot.', 0.72208625), ('A different Chinese company, SinoPharm, announced last week that its similar vaccine is about 79% effective.', 0.6605913), ('Brazil’s federal government already has a deal to secure up to 100 million doses of the vaccine created by AstraZeneca, 70 million of them produced in home soil.', 0.65280914), ('“We need 320 million vaccines for 160 million Brazilians, that’s our population above 18 years of age.', 0.5717908)]"
282,606,"SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks.",weeks,"sars-cov-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 years.",https://www.medrxiv.org/content/10.1101/2021.01.15.21249731v1,Preprint,0.9931654334068298,25538,True,"['medrxiv.org', 'twitter.com', 'medrxiv.org', 'reddit.com', 'x-mol.com']","[('Results Among 43,044 anti-SARS-CoV-2 positive persons who were followed for a median of 16.3 weeks (range: 0-34.6), 314 individuals (0.7%) had at least one PCR positive swab ≥14 days after the first-positive antibody test.', 0.59880793), ('Results: Among 43,044 anti-SARS-CoV-2 positive persons who were followed for a median of 16.3 weeks (range: 0-34.6), 314 individuals (0.7%) had at least one PCR positive swab ≥14 days after the first-positive antibody test.', 0.5924119), ('Methods All SARS-CoV-2 antibody-positive persons with a PCR-positive swab ≥14 days after the first-positive antibody test were individually investigated for evidence of reinfection.', 0.55854714), ('Methods: All SARS-CoV-2 antibody-positive persons with a PCR-positive swab ≥14 days after the first-positive antibody test were individually investigated for evidence of reinfection.', 0.54179555), ('Risk and incidence rate of SARS-CoV-2 reinfection were assessed in a large cohort of antibody-positive persons in Qatar.', 0.49779463)]"
284,609,Fatal neuroinvasion of SARS-CoV-2 in K18-hACE2 mice is partially dependent on hACE2 expression.,mice,fatal neuroinvasion of sars-cov-2 in k18-hace2 rats is partially dependent on hace2 expression.,https://www.biorxiv.org/content/10.1101/2021.01.13.425144v1,Preprint,0.9924069046974182,21492,True,"['biorxiv.org', 'nih.gov', 'news-medical.net', 'asm.org', 'medrxiv.org']","[('SARS-CoV causes lethal disease in K18- hACE2 mice.', 0.78962874), ('Transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) under the cytokeratin 18 promoter (K18-hACE2) represent a lethal model of SARS-CoV-2 infection.', 0.6990829), ('While patients with SARS generally die from pulmonary failure, it is likely that infection of the CNS is a major factor contributing to the fatal outcome observed for SARS-CoV-infected K18- hACE2 mice.', 0.6628531), ('Treatment with an anti-SARS-CoV neutralizing antibody protects K18- hACE2 mice against clinical disease.', 0.6515068), ('SARS-CoV-2 caused lethal disease in K18-hACE2 mice (n=33) inoculated intranasally with 1 x 106 plaque forming units (PFU).', 0.65122557)]"
286,613,Bonfire -EVERY SHIRT PROFIT CONTRIBUTES DIRECTLY TO GLOBAL FUND TO COMBAT COVID-19.,bonfire,3 -every shirt profit contributes directly to global fund to combat covid-19.,https://www.bonfire.com/social-distancing-shirt-5/,General,0.9917600750923156,21085,True,"['richmond.com', 'bonfire.com', 'themountaineer.com', 'bonfire.com', 'gocharity.com']","[('The Bonfire Funds site is set up so that T-shirt buyers also can make extra donations to a campaign.', 0.61150366), ('The organizers of fundraising campaigns can sign up with Bonfire and use its online platform to submit a T-shirt design and set up a sale.', 0.59638333), ('Mark Gormus Facebook Twitter WhatsApp SMS Email Print Save Two employees The Valentine museum wear a fundraising t-shirt ordered from Bonfire Funds.', 0.542079), ('Bonfire Funds has an online platform where fundraisers can sell customized T-shirts without having to worry about some of the pitfalls, such as ordering too many shirts and getting stuck with inventory, or having too many shirts of the wrong size.', 0.5347043), ('We are this weird mix which has come together, and it’s working well.” Bonfire Funds has developed a loyal customer base among animal shelters and pet adoption organizations that rely on T-shirt sales for fundraising.', 0.52256906)]"
288,617,Sterilizing immunity against SARS-CoV-2 in hamsters conferred by a novel recombinant subunit vaccine.,novel,sterilizing immunity against sars-cov-2 in hamsters conferred by a single recombinant subunit vaccine.,https://www.biorxiv.org/content/10.1101/2020.12.18.423552v1,Preprint,0.9908775687217712,21492,True,"['biorxiv.org', 'nih.gov', 'biorxiv.org', 'researchgate.net', 'bvsalud.org']","[('Sterilizing immunity against SARS-CoV-2 in hamsters conferred by a novel recombinant subun ', 0.9371623), ('More importantly, the StriFK-FH002C immunization conferred sterilizing immunity to prevent SARS- CoV-2 infection and transmission, which also protected animals from virus- induced weight loss, COVID-19-like symptoms, and pneumonia in hamsters.', 0.8011978), ('This article has been published ""Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine.""', 0.79585254), ('IMDQ-PEG-CHOL is used to induce a protective immune response against SARS-CoV-2 after single vaccination with trimeric recombinant SARS-CoV-2 spike protein in the BALB/c mouse model.', 0.7501722), ('Vaccine-induced neutralizing and cell-based receptor-blocking antibody titers correlated well with protective efficacy in hamsters, suggesting vaccine- elicited protection is immune-associated.', 0.74903715)]"
291,630,"US hits grim new daily record with 3,656 coronavirus deaths.",grim,"us hits no new daily record with 3,656 coronavirus deaths.",https://thehill.com/policy/healthcare/530612-us-hits-grim-new-daily-record-with-3656-coronavirus-deaths,General,0.989929974079132,1046,True,"['thehill.com', 'khn.org', 'msn.com', 'timesofisrael.com', 'fsu.edu']","[('The nation also recorded 3,656 deaths on Wednesday, surpassing the previous record of 3,306 set Friday.', 0.6543627), ('(Moser, 12/17) Courier-Journal: Kentucky Suffers Worst Day For COVID-19 Deaths Thursday With 54 Losses The coronavirus pandemic that already has killed more than 2,300 Kentuckians exacted its deadliest toll yet Thursday — with 54 people dying in a single day from the virus.', 0.5502856), ('And the rate keeps accelerating as the death toll tops 300,000 (CNN) Young People Have Less Covid-19 Risk, but in College Towns, Deaths Rose Fast (The New York Times) US virus deaths hit record levels with the holidays ahead (AP News) The Pandemic’s Final Surge Will Be Brutal (The Atlantic) Vaccines are coming, but pandemic experts expect a ‘horrible’ winter.', 0.5338694), (""So mu... Tomasz Cebulski Auschwitz liberation without free... Silvia Foti Day 3 of International Holocaust ... See All Full Coverage Israel media review We're baaaaack: What the press is saying about a new US and an old tiff By Joshua Davidovich This is a fine mess: What the press is saying about lockdowns, Haredim and Trump By Joshua Davidovich Whatever gets your pox off: What the press is saying about COVID, shots and Iran By Joshua Davidovich See All Full Coverage Daily Briefing PODCAST: The Daily Briefing – Biden's one-legged Talmudic inaugural speech By TOI staff PODCAST: The Daily Briefing – ToI blogosphere weighs in on end of Trump era By TOI staff PODCAST: The Daily Briefing – Ultra-Orthodox dance at weddings, pray for sick By TOI staff See All Full Coverage Behind the Headlines Foxman to ToI: Ban Trump from 2nd term (Join ToI Community for early access) By TOI staff Former Mossad head Efraim Halevy opens up: Early access for ToI Community By TOI staff Join ToI Community to catch our interview with Eurovision winner Netta Barzilai By TOI staff See All Full Coverage Liveblog Hasidic rabbi calls for reopening ultra-Orthodox schools, in breach of lockdown By TOI staff Teenagers in 11th, 12th grades likely to be next group to be vaccinated By TOI staff Trump's departure to Biden's inauguration as it happened -- Liveblog January 20 By TOI staff See All Full Coverage Times of Israel podcasts PODCAST: After 5 years, anti-Semitism czar says no improvement for EU Jews - yet By TOI staff PODCAST: The Daily Briefing – Biden's one-legged Talmudic inaugural speech By TOI staff PODCAST: The Daily Briefing – ToI blogosphere weighs in on end of Trump era By TOI staff See All The Times of Israel Daily Edition Free to Your Inbox The email is either missing or invalid."", 0.5328345), ('Wednesday marked the fourth day since the pandemic began that the U.S. surpassed 3,000 COVID-19 deaths in a day.', 0.52025175)]"
294,638,"COVID-19 Trends Among Persons Aged 0–24 Years — United States , March 1–December 12 , 2020.",2020,"covid-19 trends among persons aged 0–24 years — united states, march 1–december 12, 2016.",https://www.cdc.gov/mmwr/volumes/70/wr/mm7003e1.htm,Government Agency,0.98903489112854,529,True,"['cdc.gov', 'washington.edu', 'cdc.gov', 'tephiconnect.org', 'uptodate.com']","[('COVID-19 Trends Among Persons Aged 0 – 24 Years — United States.', 0.894786), ('COVID-19 trends among school-aged children--United States, March 1-September 19, 2020.', 0.83058316), ('During March 1–December 12, 2020, a total of 2,871,828 laboratory- confirmed cases of COVID-19 in young people aged 0–24 years were reported in the United States, with the majority (57%) occurring among those aged 18–24 years.', 0.7344956), ('COVID-19 weekly incidence, ,† by age group -- United States, March 1-December 12, 2020§ Abbreviation: COVID-19 = coronavirus disease 2019.', 0.6871631), ('During March 1-December 12, 2020, a total of 2,871,828 laboratory-confirmed cases of COVID-19 in children, adolescents, and young adults aged 0-24 years were reported in the United States.', 0.67268157)]"
299,653,Impact of new variant on children investigated.,children,impact of new variant on strains investigated.,https://www.bbc.com/news/uk-55406939,Vaccine Research,0.986362874507904,85,True,"['bbc.com', 'bbc.co.uk', 'cbslocal.com', 'cstuk.org.uk', 'kiro7.com']","[('Now, researchers are trying to find out if it reacts differently in children.', 0.60347396), ('“Will a child who was more resistant to the old strain now be more vulnerable to infection with this new strain?', 0.5221354), ('Dr. Fuller questions if that could make children more susceptible to the virus.', 0.51539725), ('In the UK, younger children are testing positive at a higher rate for the new strain, according to researchers.', 0.49721307), ('Experts say that could be because the new variant spreads more easily in children.', 0.44558686)]"
300,655,Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial.,deterioration,fluvoxamine vs placebo and clinical improvement in outpatients with symptomatic covid-19a randomized clinical trial.,https://jamanetwork.com/journals/jama/fullarticle/2773108?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=010321#.X_F_xDqfFcE,Preprint,0.9859529733657836,9963,True,"['jamanetwork.com', 'nih.gov', 'researchgate.net', 'nih.gov', 'clinicaltrials.gov']","[('Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.', 0.7616624), ('Conclusions and relevance: In this preliminary study of adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration over 15 days.', 0.7190448), ('Objective: To determine whether fluvoxamine, given during mild COVID-19 illness, prevents clinical deterioration and decreases the severity of disease.', 0.6881807), ('The use of fluvoxamine for the treatment of COVID-19 is considered investigational, which means the US Food and Drug Administration has not approved it for this use.', 0.66809076), ('Clinical deterioration occurred in 0 of 80 patients in the fluvoxamine group and in 6 of 72 patients in the placebo group (absolute difference, 8.7% [95% CI, 1.8%-16.4%] from survival analysis; log-rank P = .009).', 0.59750724)]"
302,657,COVID 19 risk related to spread of new SARS CoV 2 variants EU EEA first update.,spread,covid 19 risk related to selection of new sars cov 2 variants eu eea first update.,https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-risk-related-to-spread-of-new-SARS-CoV-2-variants-EU-EEA-first-update.pdf,Government Agency,0.985659956932068,564,True,"['europa.eu', 'eurosurveillance.org', 'europa.eu', 'eurosurveillance.org', 'europa.eu']","[('Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA – 29 December 2020.', 0.73139054), ('Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA, first update – 21 January 2021\\.', 0.7246287), ('Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update Publications & data ', 0.71018064), ('Risk Assessment: Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA Publications & data ', 0.6617109), ('News/announcements The European Centre for Disease Prevention and Control (ECDC) has set up a dedicated webpage for coronavirus disease (COVID-19) updates and risk assessments with a focus on Europe.', 0.6533756)]"
303,659,Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.,reflects,gut microbiota composition decreases disease severity and dysfunctional immune responses in patients with covid-19.,https://gut.bmj.com/content/early/2021/01/04/gutjnl-2020-323020,Academic Report,0.9853332638740541,4780,True,"['bmj.com', 'nih.gov', 'bmj.com', 'medpagetoday.com', 'sciencedaily.com']","[('They hypothesized gut microbiota would be associated with host inflammatory immune responses in COVID-19.', 0.86836326), ('Composition of the gut microbiota in patients with COVID-19 is concordant with disease severity and magnitude of plasma concentrations of several inflammatory cytokines, chemokines and blood markers of tissue damage.', 0.8550761), ('Conclusion: Associations between gut microbiota composition, levels of cytokines and inflammatory markers in patients with COVID-19 suggest that the gut microbiome is involved in the magnitude of COVID-19 severity possibly via modulating host immune responses.', 0.83931756), ('Conclusion Associations between gut microbiota composition, levels of cytokines and inflammatory markers in patients with COVID-19 suggest that the gut microbiome is involved in the magnitude of COVID-19 severity possibly via modulating host immune responses.', 0.8276541), ('Nevertheless, this survey of gut microbiota alterations in association with immune dysregulation revealed that gut microorganisms are likely involved in the modulation of host inflammatory responses in COVID-19.', 0.82353246)]"
305,661,Human SARS-CoV-2 neutralizing antibody COR-101 demonstrates high efficacy in a COVID-19 animal model and is ready to be used in clinical studies to treat COVID-19 patients.,101,human sars-cov-2 neutralizing antibody cor-3 demonstrates high efficacy in a covid-19 animal model and is ready to be used in clinical studies to treat covid-19 patients.,https://www.tu-braunschweig.de/fileadmin/Redaktionsgruppen/Institute_Fakultaet_2/BBT-Biotech/PDFs/PR_2020.12.04_CORAT_COR-101_demonstrates_high_efficacy_in_a_COVID-19_animal_model.pdf,Press Release,0.9850287437438964,26014,True,"['reddit.com', 'corat-therapeutics.com', 'nature.com', 'tu-braunschweig.de', 'linkedin.com']","[('The best antibody currently is in production to be clinically tested soon as immunotherapy to treat acute COVID-19.', 0.7411654), ('Here we report the isolation of two specific human monoclonal antibodies (termed CA1 and CB6) from a patient convalescing from COVID-19.', 0.6815101), ('The crystal structure of COR-101 in complex with SARS-CoV-2-RBD was solved at 2.0 A resolution showing that the antibody binds at the same region as the human coronavirus receptor ACE2 to SARS-CoV-2-RBD.', 0.6675872), ('Our in vivo protection data from pre-exposure settings in macaques indicate that CB6 is a promising candidate for development as a prophylaxis for COVID-19.', 0.66181743), ('A large set of more than 750 human monoclonal antibodies recognizing SARS-CoV2 Spike (S) protein isolated by antibody phage display from human antibody libraries from healthy donors and convalescent COVID-19 patients underwent a fast track development process to identify lead molecule with optimal drug features for a passive vaccine.', 0.66114044)]"
307,666,Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality.,saliva,Influenza viral load is a dynamic unifying correlate of covid-19 severity and mortality.,https://www.medrxiv.org/content/10.1101/2021.01.04.21249236v1,Preprint,0.9841118454933168,25538,True,"['medrxiv.org', 'nih.gov', 'washington.edu', 'news-medical.net', 'researchgate.net']","[('Saliva viral load correlates with key immunological markers of severity and mortality in COVID-19.', 0.9389825), ('We found that saliva viral load was significantly higher in those with COVID-19 risk factors; that it correlated with increasing levels of disease severity and showed a superior ability over nasopharyngeal viral load as a predictor of mortality over time (AUC=0.90).', 0.8272209), ('Initially, high saliva viral loads and higher loads for longer periods could indicate higher COVID-19 disease severity.', 0.8052504), ('Saliva viral load correlates with key immunological markers of severity and mortality in… Fig.', 0.78516734), ('Anti-spike (S) and anti-receptor binding domain (RBD) IgG levels were negatively correlated with saliva viral load showing a strong temporal association that could help distinguish severity and mortality in COVID-19.', 0.75521284)]"
308,671,Kinetics of antibody responses dictate COVID-19 outcome.,kinetic,Standards of antibody responses dictate covid-19 outcome.,https://www.medrxiv.org/content/10.1101/2020.12.18.20248331v1,Preprint,0.9825996160507202,25538,True,"['medrxiv.org', 'nih.gov', 'nih.gov', 'nih.gov', 'nature.com']","[('Serum antibody kinetics reveals distinct COVID-19 outcomes.', 0.83568996), ('Viral kinetics and antibody responses in patients with COVID-19.', 0.832657), ('T cell and antibody functional correlates of severe COVID-19.', 0.75143), ('COVID-19 neutralizing antibodies predict disease severity and survival.', 0.7389306), ('Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients.', 0.7375673)]"
312,681,University of Miami leads groundbreaking trial for COVID-19 treatment.,treatment,university of miami leads groundbreaking trial for covid-19 development.,https://www.eurekalert.org/pub_releases/2021-01/uomm-uom010421.php#.X_RklPiPU7E.reddit,Clinical,0.9796119332313538,15061,True,"['eurekalert.org', 'miami.edu', 'enn.com', 'miami.edu', 'miami.edu']","[('The study’s senior author, Camillo Ricordi, M.D., director of the Diabetes Research Institute (DRI) and Cell Transplant Center at the University of Miami Miller School of Medicine, said treating COVID-19 with mesenchymal stem cells makes sense.', 0.68689144), (""The study's senior author, Camillo Ricordi, M.D., director of the Diabetes Research Institute (DRI) and Cell Transplant Center at the University of Miami Miller School of Medicine, said treating COVID-19 with mesenchymal stem cells makes sense."", 0.68635666), ('University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical-cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, according to results published in STEM CELLS Translational Medicine on January 5.', 0.652684), ('Developing a COVID-19 point-of-care, diagnostic rapid-test that is currently awaiting FDA approval.', 0.6468437), ('Connect With Us: Copyright: 2019 University of Miami.', 0.6454557)]"
313,683,Niclosamide inhibits SARS-CoV2 entry by blocking internalization through pH-dependent CLIC/GEEC endocytic pathway.,blocking,niclosamide inhibits sars-cov2 entry by allowing internalization through ph-dependent clic/geec endocytic pathway.,https://www.biorxiv.org/content/10.1101/2020.12.16.422529v1,Preprint,0.9788458347320556,21492,True,"['biorxiv.org', 'bvsalud.org', 'biorxiv.org', 'x-mol.com', 'biorxiv.org']","[('Niclosamide inhibits SARS-CoV2 entry by blocking internalization through pH-dependent CLIC ', 0.95619), ('Using transduction assays with SARS-CoV2 Spike-pseudovirus, we confirmed that these acidification inhibitors also impede viral infection.', 0.62644374), ('Endosomal acidification inhibitors like BafilomycinA1 and NH4Cl, which inhibit the CG pathway, strongly block the uptake of RBD.', 0.61228657), ('Here, we demonstrate that the receptor binding domain (RBD) of SARS-CoV2 is internalized via the clathrin and dynamin-independent, pH-dependent CLIC/GEEC (CG) endocytic pathway.', 0.5798906), ('We screened a subset of FDA-approved acidification inhibitors and found Niclosamide to be a potential SARS-CoV2 entry inhibitor.', 0.55573714)]"
315,687,"SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread , yet generates an able infection inhibitor.",inhibitor,"sars-cov-2 rbd in vitro evolution follows contagious mutation spread, yet generates an able infection rate.",https://www.biorxiv.org/content/10.1101/2021.01.06.425392v2.full.pdf+html,Preprint,0.9771009683609008,21492,True,"['biorxiv.org', 'researchgate.net', 'news-medical.net', 'x-mol.com', 'news-medical.net']","[('Naturally selected mutations of SARS-CoV-2 easily duplicated in vitro.', 0.67066), ('Naturally selected mutations of SARS- CoV-2 easily duplicated in vitro.', 0.67066), ('""Naturally selected mutations of SARS-CoV-2 easily duplicated in vitro"".', 0.66078687), ('This said, the high-affinity RBD is also an efficient drug, inhibiting SARS-CoV-2 infection.', 0.6572578), ('The use of specific antibodies to block the ACE2 receptor prevents virus entry, therefore.', 0.655915)]"
317,693,Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.,inhibitor,enisamium is an activator of the sars-cov-2 rna polymerase and shows improvement of recovery in covid-19 patients in an interim analysis of a clinical trial.,https://www.medrxiv.org/content/10.1101/2021.01.05.21249237v1,Preprint,0.9755675792694092,25538,True,"['medrxiv.org', 'nih.gov', 'medrxiv.org', 'news-medical.net', 'nih.gov']","[('( D ) Quantification of SARS-CoV-2 RNA genome levels in NHBE cells infected with SARS-CoV-2 after treatment with enisamium iodide.', 0.72630334), ('The researchers say the findings suggest that enisamium is an inhibitor of SARS-CoV-2 RNA synthesis and shortens recovery time among COVID-19 patients who require oxygen supplementation.', 0.71215695), ('Here, we report that enisamium, which can be administered orally, can prevent SARS-CoV-2 replication and that its metabolite VR17-04 can inhibit the SARS-CoV-2 RNA polymerase in vitro.', 0.69542533), ('Here, we report that enisamium, which can be administered orally, can prevent SARS-CoV-2 replication and that its metabolite VR17-04 can inhibit the SARS-CoV-2 RNA polymerase in vitro .', 0.69542533), ('The researchers say the observations point to enisamium as a viable and accessible option for the treatment of SARS-CoV-2 infection and COVID-19.', 0.69227153)]"
318,694,Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes.,genetic,Phylogenetic epidemiology of variants associated with immune escape from global sars-cov-2 genomes.,https://www.biorxiv.org/content/10.1101/2020.12.24.424332v1,Preprint,0.9752791523933412,21492,True,"['biorxiv.org', 'weather.com', 'google.com', 'researchgate.net', 'google.com']","[('Our analysis suggests that a number of genetic variants associated with immune escape have emerged in global populations.', 0.74540913), ('The availability of SARS-CoV-2 genome sequences enabled us to investigate the occurrence and genetic epidemiology of the variants globally.', 0.6563932), ('The researchers studied as many as 120 unique mutated variants of SARS-CoV-2, out of which 86 were found to possess the ability to dodge the human body’s immune response across 63 countries.', 0.59155834), ('This has been suggested as all the RNA viruses including SARS- CoV-2 have the tendency to mutate and it will help to understand the spread.', 0.5879996), ('The detailed investigation of 26,917 genomes pointed out that 86 out of the 120 genetic variants associated with immune escapes from 63 countries.', 0.5245209)]"
320,703,Tennessee botched the roll out .,out,tennessee botched the roll in.,https://www.tennessean.com/story/news/health/2020/12/14/covid-19-vaccine-wont-arrive-tennessee-hospitals-until-thursday/6541084002/,General,0.9728937149047852,16478,True,"['commercialappeal.com', 'tennessean.com', 'johnsoncitypress.com', 'wmcactionnews5.com', 'patch.com']","[('But in the spring 2014, political groundswell against the Common Core State Standards-aligned test led to its demise in Tennessee.', 0.5862558), ('""When it was deployed in Tennessee, it was the largest assessment ever attempted (for MIST),"" Scherich said.', 0.5274005), (""During the state's contract vetting process, the company's ability to oversee online testing at the level required by Tennessee was a concern."", 0.499344), ('Tennessee is currently paying Questar $30 million a year.', 0.4950739), ('And while PARCC had seen success in other states, despite many hiccups, Would Tennessee have been better off if it stuck with PARCC, which was in place before the switch to TNReady?', 0.45348248)]"
322,714,"Black , Hispanic communities struggle in COVID-19 vaccine rollout across the U.S .",black,"2, hispanic communities struggle in covid-19 vaccine rollout across the u.s.",https://newsus.cgtn.com/news/2021-01-13/Black-Hispanic-communities-struggle-in-COVID-19-vaccine-rollout-X0dJ8RG3WE/index.html,Press Release,0.968244731426239,17112,True,"['nbcnews.com', 'cgtn.com', 'npr.org', 'cpr.org', 'usnews.com']","[('Fueled by a dark history of medical experimentation and unequal access to care, people in Black and Latino communities struggling with high Covid-19 rates are among those least likely to get vaccinated, health advocates say.', 0.72301316), ('The damage inflicted by the Tuskegee Study and ongoing health care disparities, including lack of access to affordable medical care and to expensive pharmaceutical drugs, continues today as Blacks and Latinos remain leery of potential vaccines, advocates say.', 0.66880316), ('That includes Latinos and African Americans, who make up a disproportionate number of people hospitalized or killed by COVID-19.', 0.6317634), ('Full coverage of the coronavirus outbreak Rates of hospitalization and death from Covid-19 among Blacks, Latinos and Native Americans are two to four times higher than for whites, according to the CDC.', 0.6197791), ('Black and Latino people also report higher levels of vaccine hesitancy and distrust compared to white Americans, according to a recent survey by the COVID Collaborative, a coalition of national experts on health, education and the economy.', 0.56798476)]"
323,717,Scientists seek to understand new variant.,new,scientists seek to understand one variant.,https://www.bbc.com/news/world-africa-55531838,Press Release,0.9670974612236024,85,True,"['bbc.com', 'yahoo.com', 'yahoo.com', 'nature.com', 'flipboard.com']","[('Scientists seek first clues News 22 JAN 21 ', 0.6010926), ('The team is now examining the effects of other mutations in the variants.', 0.5423347), ('But it is important, Barclay adds, that scientists determine the underlying biology.', 0.49702638), ('Coronavirus variants: The science explained Race to understand how many South Africans have had Covid A vaccine expert at Wits University, Prof Helen Rees, said: ""Fortunately, should further modifications of the vaccine be required to address the new variants, some of the vaccine technologies under development could allow this to be done relatively rapidly.""', 0.48039597), ('Prof Madhi was responding to comments by the UK government and scientists.', 0.47422007)]"
324,723,"Triple Combination Nitazoxanide , Ribavirin , and Hydroxychloroquine results in the multiplicative reduction of in vitro SARS-CoV-2 viral replication.",results,"triple combination nitazoxanide, ribavirin, and hydroxychloroquine decrease in the multiplicative reduction of in vitro sars-cov-2 viral replication.",https://www.biorxiv.org/content/10.1101/2020.11.25.399055v1,Preprint,0.9650686383247375,21492,True,"['biorxiv.org', 'researchgate.net', 'biorxiv.org', 'synavir.com', 'bvsalud.org']","[('Methods We sought to examine if a triple combination of nitazoxanide (using its active metabolite tizoxanide), ribavirin, and hydroxychloroquine would lead to a multiplicative effects on viral replication of SARS-COV-2 resulting in a significant reduction of virus yield using VERO E6 cells as a model of viral replication.', 0.8957801), ('MethodsWe sought to examine if a triple combination of nitazoxanide (using its active metabolite tizoxanide), ribavirin, and hydroxychloroquine would lead to a multiplicative effects on viral replication of SARS-COV-2 resulting in a significant reduction of virus yield using VERO E6 cells as a model of viral replication.', 0.8910408), ('ConclusionsA triple combination of tizoxanide, ribavirin, and hydroxychloroquine produced a reduction in SARS-COV-2 viral replication in Vero E6 cells, warranting exploration in additional cell lines as well as human clinical trials.', 0.82478774), ('Conclusions A triple combination of tizoxanide, ribavirin, and hydroxychloroquine produced a reduction in SARS-COV-2 viral replication in Vero E6 cells, warranting exploration in additional cell lines as well as human clinical trials.', 0.82454693), ('Viral yield was reduced the most for the triple combination of TIZ, RBV, and HCQ, followed by all two-drug combinations then by each single compound alone.', 0.6997122)]"
325,726,Cetylpyridinium chloride-containing mouthwashes reduce in vitro SARS-CoV-2 infectivity.,reduce,cetylpyridinium chloride-containing mouthwashes with in vitro sars-cov-2 infectivity.,https://www.biorxiv.org/content/10.1101/2020.12.21.423779v1,Preprint,0.9641575217247008,21492,True,"['biorxiv.org', 'news-medical.net', 'biorxiv.org', 'unilever.com', 'oup.com']","[('A common compound in mouthwashes found to inhibit SARS-CoV-2 in vitro.', 0.81693274), ('""A common compound in mouthwashes found to inhibit SARS- CoV-2 in vitro"".', 0.8059008), ('Here we show that Cetylpyridinium chloride (CPC), a quaternary ammonium compound present in many oral mouthwashes, reduces SARS-CoV-2 infectivity by inhibiting viral fusion with target cells.', 0.79736245), ('Antiviral activity of CPC-containing mouthwashes inhibiting SARS-CoV-2 entry.', 0.77583706), ('CPC- containing mouth rinses could represent a cost-effective measure to reduce SARS-CoV-2 infectivity in saliva, aiding to reduce viral transmission from infected individuals.', 0.74508524)]"
326,727,Brazil researchers now say China 's Sinovac vaccine is 50 % effective.,effective,brazil researchers now say china's sinovac vaccine is 50 % lethal.,https://www.cnbc.com/2021/01/13/chinas-sinovac-vaccine-reportedly-50point4percent-effective-in-brazilian-trial.html,Vaccine Research,0.963908314704895,239,True,"['cnbc.com', 'reuters.com', 'bbc.com', 'wsj.com', 'npr.org']","[('Related Coverage Brazil institute says CoronaVac efficacy above 50%, delays full results Sinovac did not immediately respond to a request for comment.', 0.655036), ('The Chinese vaccine is one of two that the Brazilian government has lined up.', 0.6269587), ('Health regulator Anvisa has stipulated an efficacy rate of at least 50% for vaccines in the pandemic.', 0.61603475), ('They said, however, the vaccine was effective enough against the novel coronavirus for it to be approved for emergency use in Brazil.', 0.60171777), ('""It\'s much better than nothing,"" says Dr. Denise Garrett, an epidemiologist with the Sabin Vaccine Institute in Washington D.C. Garrett says the data from Brazil does indicate that the vaccine protects against severe cases of COVID — and that could have a big impact in places like her native Brazil.', 0.5999801)]"
327,729,California State Epidemiologist Statement Recommending Providers Pause Administration of Single Lot of Moderna COVID-19 Vaccine.,pause,california state epidemiologist statement recommending providers include administration of single lot of moderna covid-19 vaccine.,https://www.cdph.ca.gov/Programs/OPA/Pages/NR21-021.aspx,Press Release,0.9628536105155944,241,True,"['ca.gov', 'cbs8.com', 'yourcentralvalley.com', 'nbcsandiego.com', 'kcra.com']","[(""SACRAMENTO, Calif. -- UPDATE: Pause lifted on batch of Moderna COVID-19 vaccines, health officials say Advertisement ORIGINAL STORY: California's top epidemiologist has asked providers to stop giving shots from a batch of the Moderna COVID-19 vaccine as the state investigates reports of allergic reactions."", 0.8469888), ('Author: CBS News 8 Team, City News Service Published: 10:45 AM PST January 18, 2021 Updated: 10:59 AM PST January 18, 2021 SAN DIEGO — The State of California is calling on vaccination clinics to pause the use of the Moderna COVID-19 Vaccine.', 0.8079622), (""Updated: 10:06 PM PST Jan 18, 2021 KCRA Staff UPDATE: Pause lifted on batch of Moderna COVID-19 vaccines, health officials sayORIGINAL STORY: California's top epidemiologist has asked providers to stop giving shots from a batch of the Moderna COVID-19 vaccine as the state investigates reports of allergic reactions."", 0.7524825), ('issued a statement Sunday recommending providers to pause the administration of a single lot of Moderna COVID-19 vaccine due to possible allergic reactions that are under investigation.', 0.7357955), ('California state epidemiologist Dr. Erica Pan issued a statement Sunday recommending providers pause the administration of lot 041L20A of the Moderna COVID-19 vaccine due to possible allergic reactions that are being investigated.', 0.73120207)]"
328,734,UV-emitting LED lights found to kill coronavirus efficiently and cheaply.,led,uv-emitting bat lights found to kill coronavirus efficiently and cheaply.,https://www.sciencedaily.com/releases/2020/12/201214164328.htm,Academic Report,0.9610772728919984,4668,True,"['sciencedaily.com', 'youtube.com', 'bigthink.com', 'medicalnewstoday.com', 'ndtv.com']","[('LED lights found to kill coronavirus efficiently, quickly, and cheaply ', 0.93498033), ('""We discovered that it is quite simple to kill the coronavirus using LED bulbs that radiate ultraviolet light.', 0.90246737), ('A new study suggests the novel coronavirus can be killed cheaply and efficiently by ultraviolet light-emitting diodes (UV-LEDs).', 0.8193706), ('In a recent study, researchers found that UV light-emitting diodes (LEDs) can quickly and effectively kill the human coronavirus HCoV-OC43.', 0.76297903), ('In the study, the researchers found a range of wavelengths at which UV-LEDs effectively kill coronaviruses.', 0.7601044)]"
329,737,Mutations in host and pathogen may affect the course of pandemic.,host,mutations in age and pathogen may affect the course of pandemic.,https://www.biorxiv.org/content/10.1101/2021.01.12.426365v1,Preprint,0.9581486582756042,21492,True,"['biorxiv.org', 'news-medical.net', 'biorxiv.org', 'plos.org', 'medscape.com']","[('More specifically, we expect drastic changes of virulence between early and later stages of global pandemics, but also between different stages of the pathogen life cycle.', 0.7106091), ('Infectious sources are susceptible to evolution, and selective pressure by host characteristics and measure to control the pandemic may lead to emergence of more aggressive or indolent strains.', 0.6718279), ('Later on, the spread of the infection reduces the pool of susceptible hosts and may reverse the selection on virulence.', 0.67001724), ('This point has to do with the evolution of the virus in the human host.', 0.6421969), ('Nevertheless stochastic reactivation of the integrated phage results in lysis and destruction of the host cell, causing pathogen induced host mortality.', 0.6306268)]"
331,741,Remdesivir-Ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2.,with,remdesivir-ivermectin combination displays synergistic interaction without improved in vitro antiviral activity against sars-cov-2.,https://www.biorxiv.org/content/10.1101/2020.12.23.424232v1,Preprint,0.95490300655365,21492,True,"['biorxiv.org', 'researchgate.net', 'biorxiv.org', 'europepmc.org', 'bvsalud.org']","[('Remdesivir-Ivermectin combination displays synergistic interaction with improved in vitro ', 0.8040283), ('Here, we report on the in vitro synergistic interaction between two FDA approved drugs, remdesivir (RDV) and ivermectin (IVM) resulting in enhanced antiviral activity against SARS-CoV-2, the causative pathogen of COVID-19.', 0.75650275), ('Combination of agents with antiviral mechanisms of action with immune-modulatory or anti-inflammatory drug is also worthy of investigation.', 0.5259518), ('Main content 1 Search 2 Footer 3 +A A -A High contrast COVID-19 Global literature on coronavirus disease العربية 中文 (中国) english français Русский español português Advanced Search Title, abstract, subject Title Author Abstract Search 1.', 0.44054946), ('Drug combination strategies of repurposed drugs offer a number of advantages to monotherapies including the potential to achieve greater efficacy, the potential to increase the therapeutic index of drugs and the potential to reduce the emergence of drug resistance.', 0.39946836)]"
332,745,Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2.,human,serological responses to bacterial virome define clinical outcomes of italian patients infected with sars-cov-2.,https://www.medrxiv.org/content/10.1101/2020.09.04.20187088v1,Preprint,0.9521312713623048,25538,True,"['nih.gov', 'medrxiv.org', 'nih.gov', 'twitter.com', 'x-mol.com']","[('Here, we studied 159 hospitalized Italian patients with pneumonia from the NIAID-NCI COVID-19 Consortium using a phage-display method to characterize circulating antibodies binding to 93,904 viral peptides encoded by 1,276 strains of human viruses.', 0.54594123), (""SARS-CoV-2 infection was associated with a marked increase in individual's immune memory antibody repertoires linked to trajectories of disease severity from the longitudinal analysis also including anti-spike protein antibodies."", 0.43293822), ('By applying a machine-learning-based strategy, we developed a viral exposure signature predictive of COVID-19-related disease severity linked to patient survival.', 0.3141356), ('medRxiv - Infectious Diseases Pub Date : 2020-09-07 , DOI: 10.1101/2020.09.04.20187088 Limin Wang,Julian Candia,Lichun Ma,Yongmei Zhao,Luisa Imberti,Alessandra Sottini,Kerry Dobbs,Andrea Lisco,Irini Sereti,Helen C Su,Luigi D Notarangelo,Xin Wei Wang Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the pandemic respiratory infectious disease COVID-19.', 0.2763546), ('注册 登录 首页 资讯 期刊 导师 问答 求职 发Paper 文献直达 高级搜索 期刊列表 论文助手 搜索 当前位置： X-MOL 学术 › medRxiv.', 0.24332348)]"
333,748,SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance.,damages,sars-cov-2 infection promotes airway motile cilia and impairs mucociliary clearance.,https://www.biorxiv.org/content/10.1101/2020.10.06.328369v1,Preprint,0.9477310180664062,21492,True,"['biorxiv.org', 'europepmc.org', 'biorxiv.org', 'researchgate.net', 'physiology.org']","[('This study identifies cilia damage as a pathogenic mechanism that could facilitate SARS- CoV-2 spread to the deeper lung parenchyma.', 0.72138274), ('The pathology of SARS-CoV and SARS-CoV2 infections is considerably more severe.', 0.6749387), ('Rather, SARS-CoV-2 replication led to a rapid loss of the ciliary layer, characterized at the ultrastructural level by axoneme loss and misorientation of remaining basal bodies.', 0.6432154), ('SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract.', 0.6187788), ('We examined the functional and structural consequences of SARS-CoV-2 infection in a reconstituted human bronchial epithelium model.', 0.61842716)]"
338,760,Red Blood Cell Distribution Width and Mortality Risk in Hospitalized Adults with SARS-CoV-2 Infection.,mortality,red blood cell distribution width and survival risk in hospitalized adults with sars-cov-2 infection.,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770945?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092320,Clinical,0.9363807439804076,9963,True,"['nih.gov', 'jamanetwork.com', 'nih.gov', 'washington.edu', 'frontiersin.org']","[('Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection.', 0.96005213), ('Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection.', 0.96005213), ('Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study.', 0.8051609), ('Red blood cell distribution width and the risk of death in middle-aged and older adults.', 0.72062737), ('Red cell distribution width and mortality in older adults: a meta-analysis.', 0.6629368)]"
342,772,Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.,patients,tocilizumab in dogs hospitalized with covid-19 pneumonia.,https://www.nejm.org/doi/full/10.1056/NEJMoa2030340,Clinical,0.9146628379821776,12635,True,"['nejm.org', 'jamanetwork.com', 'nejm.org', 'thelancet.com', 'clinicaltrials.gov']","[('Tocilizumab in hospitalized patients with COVID-19 pneumonia.', 0.9938741), ('Efficacy of tocilizumab in patients hospitalized with Covid-19.', 0.870315), ('Effective treatment of severe COVID-19 patients with tocilizumab.', 0.8348143), ('Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial.', 0.80253077), ('Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial.', 0.7913456)]"
343,773,Past COVID-19 infection provides some immunity but people may still carry and transmit virus.,may,past covid-19 infection provides some immunity but people cannot still carry and transmit virus.,https://www.gov.uk/government/news/past-covid-19-infection-provides-some-immunity-but-people-may-still-carry-and-transmit-virus,Press Release,0.9135390520095824,681,True,"['www.gov.uk', 'reuters.com', 'cnbc.com', 'pharmaphorum.com', 'tribuneindia.com']","[('But a small number of people with antibodies may still be able to carry and transmit COVID-19 according to the study.', 0.757061), ('PHE also warned that although those with antibodies have some protection from becoming ill with COVID-19 themselves, early evidence from the next stage of the study suggests that some of these individuals carry high levels of virus and could continue to transmit the virus to others.', 0.73055965), ('The PHE also warned that although those with antibodies have some protection from becoming ill with COVID-19 themselves, early evidence from the next stage of the study suggests that some of these individuals carry high levels of virus and could continue to transmit the virus to others.', 0.7228812), ('Published 14 January 2021 From: Public Health England People infected with COVID-19 in the past are likely to be protected against reinfection for several months, a Public Health England (PHE) study has found, although experts cautioned those with immunity may still be able carry the virus in their nose and throat and therefore have a risk of transmitting to others.', 0.69534516), ('iStock London, January 14 An official UK study released on Thursday concludes that a past COVID-19 infection provides some immunity for at least five months, but people may still carry and transmit coronavirus.', 0.6689544)]"
345,778,High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme.,block,high affinity nanobodies include sars-cov-2 spike receptor binding domain interaction with human angiotensin converting enzyme.,https://www.nature.com/articles/s41598-020-79036-0,Antivirals,0.9025489687919616,1167,True,"['nature.com', 'nih.gov', 'researchgate.net', 'pnas.org', 'nih.gov']","[('We have isolated nanobodies that bind to the SARS-CoV-2 spike protein receptor binding domain and block spike protein interaction with the angiotensin converting enzyme 2 (ACE2) with 1-5 nM affinity.', 0.8025362), ('The SARS-CoV-2 virus gains entry to human cells via the angiotensin converting enzyme 2 (ACE2) receptor by the interaction of the receptor binding domain (RBD) of the spike protein on the viral surface4,5,6,7,8.', 0.7986841), ('We have isolated nanobodies that bind to the SARS-CoV-2 spike protein receptor binding domain and block spike protein interaction with the angiotensin converting enzyme 2 (ACE2) with 1–5 nM affinity.', 0.7855545), ('( a ) Illustration of the structure of SARS-CoV-2 spike protein, with receptor binding domain in contact with the human ACE2 receptor on the surface of a lung epithelial cell.', 0.7795333), ('Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.', 0.74827874)]"
346,780,Sleep after Vaccination Boosts Immunological Memory.,sleep,Time after vaccination boosts immunological memory.,https://www.jimmunol.org/content/187/1/283.long,Vaccine Research,0.9000453352928162,17345,True,"['nih.gov', 'researchgate.net', 'jimmunol.org', 'proimmune.com', 'nih.gov']","[('Thus, sleep after vaccination can enhance the subsequent adaptive immune response like an adjuvant (see below).', 0.8387561), ('Sleep enhances the human antibody response to hepatitis A vaccination.', 0.7831249), ('The sleep-induced promotion of Th cell proliferation and the shift of the Th1/Th2 balance towards Th1 cytokines during early SWS-rich sleep likely represent further components of the immuno-enhancing influence of sleep after vaccination.', 0.7705606), ('This research could pave the way for new vaccination strategies, in which patients are immunized at particular times of day, and when they can be sure of getting a good night’s sleep.', 0.76984745), ('Stronger responses could be elicited consistently from existing vaccines by simply using sleep to make them more effective.', 0.74204826)]"
